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A B S T R A C T 
The concept of vaccine against pregnancy i s an a t t r a c t i v e 
approach of f e r t i l i t y control and one which has received increasing 
a t t en t ion in the l a s t decade. The lu te in iz ing hormone (LH) and 
chorionic gonadotropin (hCG) exercise a c r i t i c a l role in the 
regulat ion of f e r t i l i t y of primates. The former is important 
in ovulation and steroidogenesis but the l a t t e r for rescue of 
corpus luteum and maintenance of steroidogenesis upto the time 
of placental s h i f t . HCG I s produced by the trophoblast ce l l s 
of placenta and i t s concentration increases rapidly post-
f e r t i l i z a t i o n . HCG is a 40 kD M.W, glyq.oprotein hormone composed 
of two non-identical subunits designated as alpha (a) and beta (3 ) . 
HCG and other re la ted p i tu ta ry hormones such as LH, FSH and TSH 
consist of nearly ident ica l alpha chains, although, the i r beta 
chains show varying degree of sequent ial homology. Therefore, 
the antibodies capable of neut ra l iz ing the biological a c t i v i t y 
of hCG may also cross react with LH. However, beta-subunit of 
LH lacks the 3-hCG specif ic C-terminal segment of 32 amino acid 
res idues . 
In the present inves t iga t ion , hCG was purified from a 
commercial preparation by gel f i l t r a t i o n and i t s puri ty was 
checked by polyacrylamide gel e lec t rophores i s . The SDS-PAGE 
revealed that the hormone comprised two diss imilar subunits, 
a and 3 , The UV i r rad ia t ion of hCG a t 254 nm was found to cause 
a dose-dependent loss in i n t r i n s i c fluorescence in tens i ty and 
UV absorbance at 275 nm. Six lysine residues were modified by 
trinitrophenylation in native hCG whereas in irradiated hCG 
only 5 residues were modified, indicating destruction of one 
lysine residue and/or structural change as a consequence of 
irradiation. The observation is substantiated by the proteolysis 
of native and irradiated hCG. In the native hCG sites of tryptic 
attack were found to be hurried but in the irradiated molecules 
these were accessible to tryptic attack due to change in structure 
of the molecule. However, as the radiation dose in increased, 
the susceptibility of hCG to trypsin decreased. This might be 
due to either the destruction of amino acids that are available 
for digestion or there is a partial change in structure of 
irradiated hCG molecule in a way that amino acids are no more 
accessible to tryptic digestion. Similar results were obtained 
on urea treatment of irradiated hCG, 
Precipitating antibodies against native and irradiated 
hCG were successfully induced in rabbits, Antisera against 
irradiated hCG showed increased antibody level with period of 
immunization. The titer was found to be 1:100, 1:A00 and 1:1600 
after second, third and fourth injections respectively. 
Immunohistological studies on the effect of native hCG on 
testes showed increased spermatogenesis while with irradiated 
sample, the maturation of sperms was arrested. These studies on 
native and irradiated hCG is indicative of the belief that 
immunogenicity and biological activity of molecules ai^ associated 
with t he i r native s t ruc tu re . UV i r r ad i a t i on has affected the 
nat ive s tructure of hCG with decreased b io logica l a c t i v i t y . 
The evaluation of binding of psoralen with hCG was 
ascer ta ined by fluorescence quenching technique and UV 
absorpt ion. The hCG-psoralen complex exhibi ted increased 
absorbance over the ent i re spectra l range of 200 nm to 370 nm. 
The fluorescence emission spectra of the complex was unchanged 
but showed a decrease in fluorescence i n t e n s i t y . The Scatchard 
p lo t analysis of the in teract ion indicates the involvement of 
four binding s i t e s (r = 3.9) with an apparent assoc ia t ion 
5 -1 
constant , Ka = 0.795 x 10 M • As a r e su l t of in t e rac t ion 
between hCG and psoralen, an increased absorption a t 275 nm was 
observed, without a change in UV absorption spec t ra . When the 
samples were subjected to gel f i l t r a t i o n on Sephadex G~100 column. 
The binding between these two in terac t ing molecules was further 
r e i t e ra t ed by the capacity of psoralen to compete in hCG-anti-hCG 
antibody system. Appreciable inhib i t ion in immunoreactivity in 
the presence of psoralen was observed. The r e s u l t s a lso indicate 
a possible correlat ion between the binding s i t e of anti-hCG 
antibody and psoralen on the hCG molecule. 
The complex of psoralen and hCG was more immunogenic than 
the free hormone and antibody t i t e r of 1:1920, 1:15360 and 
1:491520 was acquired a f t e r th i rd , fourth and f i f th in ject ions 
respect ively . In order to rule out the p o s s i b i l i t y of unspecific 
binding, inhibi t ion ELI3A was performed. The r e su l t s suggest 
t h a t a f t e r binding with psoralen, hCG became more an t igen ic . 
The binding of psoralen to subunits of hCG was a lso 
inves t iga ted . The alpha-psoralen and beta-psoralen complex 
exhibited no change in t h e i r re la t ive exci ta t ion and emission 
wavelengths but showed a s igni f icant quenching in i n t e n s i t y . 
Similar r e su l t s were obtained with u l t r av io l e t spec t ra l s tudies 
and gel f i l t r a t i o n experiments. 
Antibodies were induced in rabbi ts against complexes of 
psoralen with alpha and beta-subunits of hCG. In contras t to 
hCG-psoralen complex, the subunit complexes were l ess ant igenic 
as compared to free subuni ts . I t appears that the binding s i t e s 
of psoralen on the subunits of hCG and epitope are s imi lar in 
s t r uc tu r e . These two e n t i t y might be close to one another. 
Three peptides (PI, PII and PHI ) of 3-subunit of hCG 
were seperated and i so la ted by gel f i l t r a t i o n on Sephadex G-25 
a f t e r hydrolysis by chymotrypsin of carboxymethylated 3hCG. 
These peptides were purif ied on Sephadex G-50 and used as 
inh ib i to rs in anti-hCG and anti-3hCG ant ibodies . Maximum 
inhib i t ion was found with PI whereas no inhibi t ion obtained 
with P H I . 
Anti-PI IgG was i so la ted from anti-hCG serum by a f f i n i t y 
chromatography using a column of Sepharose 4B coupled with P I , 
The a f f in i ty purif ied an t i -P I IgG was checked for antibody 
5 
activity with hCG, 0hCG, ahCG, PI, PII and PHI in inhibition 
ELISA. No reactivity was observed with ahCG, PI and PII. 
Antibodies were only reactive with hCG and 3hCG indicating that 
epitopes on PI are part of hCG and 3hCG but not of ahCG. 
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A B S T R A C T 
The concept of vaccine against pregnancy i s an a t t r a c t i v e 
approach of f e r t i l i t y control and one which has received increasing 
a t t en t i on in the l a s t decade. The lu te in iz ing hormone (LH) and 
chorionic gonadotropin (hCG) exercise a c r i t i c a l role in the 
regula t ion of f e r t i l i t y of primates. The former is important 
in ovulation and steroidogenesis but the l a t t e r for rescue of 
corpus luteum and maintenance of steroidogenesis upto the time 
of placental s h i f t . HCG is produced by the trophoblast ce l l s 
of placenta and i t s concentration increases rapidly post-
f e r t i l i z a t i o n . HCG is a 40 kD M.W, glycoprotein hormone composed 
of two non-identical subunits designated as alpha (a) and beta (3 ) , 
HCG and other re la ted p i tu ta ry hormones such as LH, FSH and TSH 
consis t of nearly ident ica l alpha chains, although, t he i r beta 
chains show varying degree of sequential homology. Therefore, 
the antibodies capable of neutra l iz ing the biological a c t i v i t y 
of hCG may also cross react with LH, However, beta-subunit of 
LH lacks the )3-hCG specif ic C-terminal segment of 32 amino acid 
res idues . 
In the present invest igat ion, hCG was purif ied from a 
commercial preparation by gel f i l t r a t i o n and i t s pur i ty was 
checked by polyacrylamide gel e lec t rophores is . The SDS-PAGE 
revealed that the hormone comprised two diss imi lar subunits, 
a and 3 . The UV i r rad ia t ion of hCG a t 254 nm was found to cause 
a dose-dependent loss in i n t r i n s i c fluorescence in t ens i ty and 
UV absorbance at 275 nm. Six lysine residues were modified by 
trinitrophenylation in native hCG whereas in irradiated hCG 
only 5 residues were modified, indicating destruction of one 
lysine residue and/or structural change as a consequence of 
irradiation. The observation is substantiated by the proteolysis 
of native and irradiated hCG. In the native hCG sites of tryptic 
attack were found to be burried but in the irradiated molecules 
these were accessible to tryptic attack due to change in structure 
of the molecule. However, as the radiation dose in increased, 
the susceptibility of hCG to trypsin decreased. This might be 
due to either the destruction of amino acids that are available 
for digestion or there is a partial change in structure of 
irradiated hCG molecule in a way that amino acids are no more 
accessible to tryptic digestion. Similar results were obtained 
on urea treatment of irradiated hCG. 
Precipitating antibodies against native and irradiated 
hCG were successfully induced in rabbits. Antisera against 
irradiated hCG showed increased antibody level with period of 
immunization. The titer was found to be 1:100, 1:400 and 1:1600 
after second, third and fourth injections respectively, 
Immunohistological studies on the effect of native hCG on 
testes showed increased spermatogenesis while with irradiated 
sample, the maturation of sperms was arrested. These studies on 
native and irradiated hCG is indicative of the belief that 
immunogenicity and biological activity of molecules are associated 
with t he i r native s t ruc tu re , UV i r r ad ia t ion has affected the 
native s tructure of hCG with decreased biological a c t i v i t y . 
The evaluation of binding of psoralen with hCG was 
ascer ta ined by fluorescence quenching technique and UV 
absorpt ion. The hCG-psoralen complex exhibited increased 
absorbance over the ent i re spect ra l range of 200 nm to 370 nm. 
The fluorescence emission spectra of the complex was unchanged 
but showed a decrease in fluorescence i n t ens i t y . The Scatchard 
plot analysis of the in terac t ion indicates the involvement of 
four binding s i t e s ( r = 3.9) with an apparent associa t ion 
5 -1 
constant , Ka = 0.795 x 10 M . As a r e su l t of in te rac t ion 
between hCG and psoralen, an increased absorption a t 275 nm was 
observed, without a change in UV absorption spec t ra . When the 
samples were subjected to gel f i l t r a t i o n on Sephadex G-100 column, 
The binding between these two in te rac t ing molecules was further 
r e i t e r a t ed by the capacity of psoralen to compete in hCG-anti-hCG 
antibody system. Appreciable inh ib i t ion in immunoreactivity in 
the presence of psoralen was observed. The in su l t s a lso indicate 
a possible corre la t ion between the binding s i t e of anti-hCG 
antibody and psoralen on the hCG molecule. 
The complex of psoralen and hCG was more immunogenic than 
the free hormone and antibody t i t e r of 1:1920, 1:15360 and 
1:491520 was acquired a f t e r th i rd , fourth and f i f th inject ions 
respect ive ly . In order to rule out the p o s s i b i l i t y of unspecific 
binding, inhibi t ion ELI3A was performed. The r e su l t s suggest 
t h a t a f t e r binding with psoralen, hCG became more an t igen ic . 
The binding of psoralen to subunits of hCG was also 
inves t iga ted . The alpha-psoralen and beta-psoralen complex 
exhibi ted no change in t h e i r r e la t ive exc i ta t ion and emission 
wavelengths but showed a s igni f icant quenching in i n t e n s i t y . 
Similar resu l t s were obtained with u l t r a v i o l e t spec t ra l s tudies 
and gel f i l t r a t i o n experiments. 
Antibodies were induced in rabbi ts against complexes of 
psoralen with alpha and beta-subunits of hCG. In contras t to 
hCG-psoralen complex, the subunit complexes were less antigenic 
as compared to free subunits . I t appears tha t the binding s i t e s 
of psoralen on the subunits of hCG and epitope are s imi lar in 
st injcture. These two en t i t y might be close to one another. 
Three peptides (PI, PII and PHI ) of 3-subunit of hCG 
were seperated and isola ted by gel f i l t r a t i o n on Sephadex G-25 
a f t e r hydrolysis by chymotrypsin of carboxymethylated 3hCG. 
These peptides were purif ied on Sephadex G-50 and used as 
inh ib i to r s in anti-hCG and anti-3hCG ant ibodies . Maximum 
inh ib i t ion was found with PI whereas no inh ib i t ion obtained 
with P H I . 
Anti-PI IgG was isola ted from anti-hCG serum by a f f i n i t y 
chromatography using a column of Sepharose 4B coupled with PI . 
The a f f in i ty purif ied an t i -PI IgG was checked for antibody 
activity with hCG, 3hCG, ahCG, PI, PII and PHI in inhibition 
ELISA, No reactivity was observed with ahCG, PI and PII. 
Antibodies were only reactive with hCG and 3hCG indicating that 
epitopes on PI are part of hCG and phCG but not of ahCG. 
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I N T R O D U C T I O N 
An immunological approach to the prevention of pregnancy 
has received considerable a t t en t ion during the l a s t decade. 
The p i t u i t a r y lu te in iz ing hormone (LH) and human chorionic 
gonadotropin (hCO) exercise a c r i t i c a l role in the regulat ion of 
fear t i l i ty of primates. The former i s important for ovulation 
and steroidogenesis , but the l a t t e r for rescue of coi tus luteum 
upto the time of placental s h i f t . Antibodies capable of disrupting 
the act ion of hCQ should prevent progesterone and estrogen 
production by the corpus luteum tha t i s required by the endometrium 
for the support of b las tocys t . Active and passive immunologic 
approaches have been proposed for the control of f e r t i l i t y by 
antibodies intercept ing the act ion of one or both gonadotropins 
(Moudgal e t a l , 1978; Hulme e t a l , 1980j Tandon e t a l , 1981; 
Tandon e t a l , 1984). 
HCG i s a glycoprotein hormone synthesized and secreted by 
the syncytiotrophoblast c e l l s of the placenta from ear ly pregnancy 
u n t i l term. In the f i r s t t r imes te r of pregnancy the synthesis 
of the hormone reaches i t s maximum l e v e l . HCQ cons is t s of two 
subuni ts , alpha (a) and beta (3) held together by non-covalent 
bonds. The alpha chain of hCG, i s indist inguishable with other 
p i t u i t a r y hormones as f o l l i c l e stimulating hormone (FSH), 
thyrotropin (TSH) and lu te in iz ing hormone {JM), With the exception 
of TSH, a l l of the hormones are involved in the biochemistry of 
reproduction. The 3-subunits of a l l these hormones d i f fers and 
1 
confers on the hormone i t s unique biological act ivi ty (Pierce 
e t a l , 1971a). The aubunits of the hormone can be reassociated 
to restore most of the biological and immunological ac t iv i t ies 
(Pierce et al» 1971k). 
1. Chemistry of hCQ 
( i ) Chemical composition 
In hCG, the protein is covalently linked to carbohydrate. 
Preparations of high purity by biochemical and immunological 
c r i t e r i a have enabled to obtain data on the amino acid and 
carbohydrate composition of hCG (Table 1) . The most salient 
feature ot the amino acid composition of hCO is a very high proline 
content. CKaantitative estimation of carbohydrates from four 
laboratories are presented in Table 2. 
( i i ) Subunit structure 
The non-identity of the subunits of hCQ was f i r s t 
established by two groups of investigators, Canfield e t a l , (1970) 
and Swaminathan and Bahl (1970). Sequences for a-subunit and 
3-aubunit of hCG have been elucidated (Fig.1). The a-subunit 
contains 92 amino acid residues and a to ta l molecular weight of 
14,900 whereas 3-subunit contains 145 residues with a to ta l 
molecular weight of 23,000. The carboxy-texminus of 0-hCO contain 
30 amino acids which are not present in the 3-subunit of hLH. 
This extra sequence of 0-hCG is potentially of great significance 
in providing an immunological basis for distinction between 
hCG and LH. 
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TABLE 1 
Number of amino acid residues per molecule of hCG subunita 
(Morgan et al, 1975) 
Amino acids 
Alanine 
Arginine 
Aspartio aoid/Asparagine 
Cystine (half) 
Glutamic acid/Qlutamine 
Glycine 
Hist idine 
Xsoleucine 
Lysine 
Methionine 
Phenylalanine 
Proline 
Serine 
Threonine 
Tyrosine 
Valine 
a-hCG 
5 
3 
6 
10 
9 
4 
3 
4 
6 
3 
4 
7 
8 
8 
4 
7 
0-hCG 
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12 
11 
12 
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1 
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Ala — Pro — Asp - Val — Gin — Asp — Cys - Pro — Gln-
Cys — Thr — Leu — Gin - Glu - Asp — Pro — Phe — Phe-
10 
Ser - Gin — Pro — Glv — Ala - Pro ~ lie — Leu — Gin -
20 ^ 
Cys — Met ~ Gly — Cys ~ Cys — Phe - Ser — Arg — Ala -
Tyr — Pro — Thr — Pro — Leu — Arg — Ser — Lys — Lvs -
^0 CHO 
Thr - Met — Leu - V a l —Gin - L y s - Asn —Val —Thr -
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Gly - Phe - Lys - V a l - G l u - Asn - His - T h r - A l a -
80 
Cys — HIS — Cys — Ser — Thr — Cys — Tyr — Tyr — His -
90 
Lys — Ser 
F i g . l ( a ) The amino ac id sequence of a lpha - subun i t of hCG accoi^ding 
to Morgan e t a l (1975) . 
The sites of attachment of oligosaccharide chains 
(CHO) are indicated. 
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3ef — Lys — Glu — Pro — Leu — Arg — Pro — Arg — Cys-
CHO ^ ^ y 
Arg — Pro — He — Asn — Ala — Thr — Leu — Ala — Val -
10 
Glu — Lys — Glu — Gly — Cys — Pro — V a l — Cys — He -
20 CHO 
Thr — Val — Asn — Thr ~ Thr — He — Cys — Ala ~ Gly -
30 ^ 
Tyr — Cys — Pro —Thr ~ Met —Thr — Arg — Val — Leu -
•^  ^ A O 
Gin — Gly — Val — Leu — Pro ~ Ala — Leu — Pro — Gin -
Val — Val — Cys — Asn — Tyr ~ Arg — Asp — Val — Arg -
60 
Phe — Glu — Ser — He — Arg — Leu — Pro — Gly — Cys -
Pro — Arg — Gly — Val — Asn — Pro —Val — Val — Ser-
80 
Tyr — Ala — Val — Ala — Leu — Ser — Cys — Gin — Cys-
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Ala — Uu — Cys — Arg — Arg ~ Ser — Thr — Thr — Asp-
Cys — Gly — Gly — Pro — Lys — Asp — His — Pro — Leu -
100 
Thr — Cys — Asp — Asp — Pro — Arg — Phe — Gin — Asp-
no CHO 
Ser ~~ Ser — Ser — Ser — Lys — Ala — Pro — Pro — Pro-
CHO 120 CHO 
Ser — Leu — Pro — Ser — Pro — Ser — Arg — Leu — Pro" 
CHO 130 
Gly — Pro — Ser — Asp — Thr — Pro — He — Leu — Pro" 
Uo 
Gin 
F i g , l ( b ) . The amino acid sequence of beta-subunit of hCG 
according to Morgan e t a l (1975). 
The s i t e s of attachment of oligosaccharide 
chains (CHO) are indicated. 
1 / 
Each subunlt i s highly cross-l inked by d isu l f ide bonds, 
of which there are five in a-subunit and s ix in 0-aubunit. The 
pa i r ing of the half cystine residues has not yet been es tabl ished 
with ce r t a in ty . 
( i i i ) Carbohydrate composition 
HCQ contain approximately 30?^  carbohydrate, which i s made 
up of s ix different monosacdharids unitss s i a l i c ac id , L-fucose, 
I>-galactose, D-mannose, and N-acetylglucosamine and N-acetylgalac-
tosamine (Table 2 ) , HCG i s unique among glycoprotein hormones in 
i t s high content of s i a l i c acid and i t s consequent long c i rcu la tory 
half l i f e . 
The f i r s t t en ta t ive proposal for the arrangement of 
monosaccharides in hCO has been presented by Bahl (1969a). He 
showed evidence for the presence in hCG of both types of 
carbohydrate-protein linkages commonly found in glycoproteins , 
namely the N-glycosidic linkage between N-acetylglucosamine and 
an asparagine residue and the 0-glycosidic linkage involving 
N-acetylgalactosamine and a serine res idue . He proposed two 
s t ruc tures for large chains ( s t ruc tures I and IX Fig.2) and 
another s t ruc ture for the short ser ine-l inked chain (s t ruc ture 
I I I F ig .2 ) . In a l a t e r communication, Bahl (1971) assigned 
s t ructure I and s t ruc ture I I to a - and 3-subunits respec t ive ly . 
The s t ruc ture of the carbohydrate chains of a-subunit 
has been studied by Kennedy and Chaplin (1976). In contrast to 
s tudies of Bahl (1969a) which used the carboxamidomethylated 
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Fig.2. Structures for oligosaccharide chains of hCG proposed by 
Bahl (1969). Man = Mannose; Gal = galactose; 
GluNAC = N-acetylglucosamine; GelNAC = N-acetylgalactosamine 
and N-AN = N-acetylneuraminic acid (sialic acid) 
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der ivat ive of hCQ, these workers used modified a-subuni t . 
Proteolysis with t rypsin gave r i s e to various peptides and 
glycopeptides which were iden t i f i ed . By sub^Jecting the two 
glycopeptides to component analysis» i t was found tha t these 
represented the two carbohydrate chains of the parent molecule. 
By sequential removal with specif ic glycosidases of monosaccharide 
un i t s from these two glycopeptides. I t was demonstrated that? 
( i ) galactose I mannose, glucosamine and s i a l i c acid posses the 
D-configuration 
( i i ) glucosamine uni ts were N-acetylated 
( i i i ) i n the oligosaccharide chain, s i a l i c acid un i t s were 
fa r thes t from the peptide backbone, followed by D-galactose 
uni t s 
They a lso demonstrated tha t the D-galactose, D-mannose 
and N-acetylglucosamine uni t s were present in the pyranose form, 
t ha t the D-galactopyranose uni ts were l in ted in the 1 and 6 
pos i t ion! and tha t the D-mannopyranose uni t s were present in 
several forms i . e . one in a terminal non-reducing pos i t ion , one 
as a 1,2-linked res idue, some as 1,6-linked residues and some as 
1,2,6-linked branch po in t s . The N-acetylglucosamine un i t s were 
1,6-linked. 
( iv ) Physico-chemical propert ies 
Molecular weight determinations of hCO have gi-ron a wide 
range of values . Van Hell e t a l , (1968) derived a value of about 
62,000 by sedimentation equil ibrium. Bahl (1969b) reported a 
value of approximately 59»000 by gel f i l t e r a t i o n and 47fOOO by 
sedimentation equil ibrium. The higher valt^ obtained by g e l -
f i l t e r a t i o n i s consistent with the r e su l t s obtained with other 
glycoproteins (Whitaker, 1963). The calculated molecular weight 
of hCG, from the composition of subunita i s 38,000 for 0~subunit 
and 15»000 for the a-subunit (Bel l i sa r io e t a l , 1973). 
(v) Biosynthesis of hCG 
The hormone production by placenta has been confirmed only 
in humans and other primates. Tullner (197^) has reviewed data 
avai lable for primates. The s i t e of biosynthesis of, hCO i s now 
accepted to be predominently in the syncytiotrophoblast of the 
placenta (Midgley and Pierce, 1962j Mason e t a l , 1969? Okudaira 
e t a l , 1971). The mechanisms control l ing biosynthesis , storage 
and re lease of hCG are not known. 
2 . Biological Polymorphism 
Studies on the molecular forms of hCG in plasma, urine and 
p lacenta l ex t rac t s (Franchimont and Reuter, 1972j Va i tuka i t i s , 
197A; Vai tukai t is e t a l , 1976) indicated the presence in a l l 
three biological materials of native hCG and of the a-subunit 
which was immunologically s imilar to a-subunit of hCXJ. In 
addi t ion to native hCG, placental ex t rac t s in the second 
t r imes te r of pregnancy, contained a larger molecular form of the 
a-subuni t . L i t t l e 3-subunit was detected in the plasma and in 
/» 1 
placental extracts but a low molecular weight substance was found 
in urine which reacted in a radioimmunoassay for 0-hCG. 
A large immunological species of hCG was also reported by 
Tojo et al (1977) in extracts of chorionic tissue cultivated 
in vitro and in culture media. This large species of hCG, also 
eluted in the void volume during Sephadex G-100 chromatography, 
could not be distinguished immunologically from purified hCG but 
had low biological activity in the radioreceptor assay. 3ince 
the large immunological species was the predominent form in 
chorionic tissue cultivated for a short period, and the authentic 
hCG was the predominant form in the media, the authors suggested 
that the lar^ ge hCG, possibly a prohormone, synthesised initially 
in the placenta, may be converted to the active form before 
secretion into the media. 
The question of a hCG prohormone is still unsolved, but 
the finding (Landefeld, 1976) of a mRNA in placental tissue which 
in an in vitro system gave rise to a peptide of MW 16,000 which 
was very similar to a-hCG, argues against the concept of a 
single chain prohormone for hCG. 
3. Mechanism of Action 
It is generally thought that the binding of hormones to 
membrane receptors in the initial event leading to activation 
of adenylate cyclase and subsequent production of a specific 
tajTget tissue response. Human LH and hCG appear to bind to the 
o 
same receptors in a variety of species. The binding is principally 
localised to the plasma membranes, as evidenced by subcellular 
fractionation techniqiws (Rajaniemi et al, 1974j Rao, 1973) and 
electron microscopic radiography (Han et al, 1974). The binding 
of hCO and hI*H to common receptors in rat testis and ovary has 
been studied extensively (Catt and Dufau, 1973j Catt et al, 1974). 
Similar binding sites have been demonstrated in porcine granulosa 
cells in vitro and in vivo (Channing and Kammerman, 1974). 
la vitro experiments with particulate fractions from luteinised 
rat ovaries (Lee and Ryan, 1971; 1972) indicated that the binding 
of labelled hCG was specific, saturable and dependent on time 
temperature and ionic strength. Binding is of high affinity with 
-11 dissociation constant of 10 M. 
Whereas during Jdi vitro studies there is a high specificity 
of binding of hCG to gonads, but liver and kidney have been found 
to incorporate significant amounts of hCG label (Ashitaka and 
Koide, 1974j Rao and Saxena, 1973). 
k number of studies have been reported on the isolation 
and characterization of hCG receptors from different target 
organs (Lee and Ryan, 1974} Haour and Saxena, 1974). Ifee hormone 
appears to stimulate the synthesis of its own receptor. 
Pandian et al (1975) showed that hCG stimulate the incorporation 
of [ C] N-aoetyl-D-glucosamine in rat ovary in vitro and that 
an appreciable amount of radioactivity was incorporated in the 
cell surface receptor for hCG, In addition to detergent-
solubilized gonadotropin receptors, soluble gonadotropin-binding 
fac tors have been isola ted from r a t t e s t i s (Bhalla e t a l , 1976). 
125 The dissocia t ion constant of I-hCO binding to soluble factors 
was s imilar to tha t derived for membrane-bound or detergent-
so lubi l i sed receptors . 
Evidence tha t hCQ may regulate the number of i t s ovm 
receptors has been presented by Sharpe (1976). His s tudies with 
immature r a t t e s t i s jjtt v i t r o and ijn vivo suggested tha t the binding 
of hCG to specif ic gonadotropin receptors in the t e s t i s affected 
the subsequent a v a i l a b i l i t y of these receptors . 
4 . Concentration of hCO and Subunits in Placental Tissue 
Bioassay es t imates , of the concentration of hCG in f i r s t 
t r imes t e r placenta gave values in the range of 100-650 Mg of wet 
t i s sue and average values were lower in the l a s t t r imester 
(Diczfalusy, 1953). Studies by Vai tukai t i s (1974) showed tha t 
a l l the placental ex t rac t s studied contained hCG and a-hCG but 
the concentrations of the two glycoproteins varied qua l i t a t i ve ly 
and quant i ta t ive ly during progression of pregnancy. The absolute 
amount of hCG and a-hCQ decreased a f t e r the f i r s t t r imes te r but 
the re la t ive quantity of a-hCG compared with In t ac t hCO increased 
by more than 10 fold in the l a s t two t r imes te r s . An addi t ional 
species of a-subunit was ident i f ied in the second t r imes te r , 
5 . Dis t r ibut ion of hCO in Body Fluids 
Although a corre la t ion between individual mater ial and 
foe ta l concentrations of hCQ have been found, the concentration i s 
2'i 
much higher in maternal blood than in foetal blood. The ratio 
of maternal-foetal concentration was found to be 344i1 (Geiger 
et al, 1971). Somewhat higher values for the maternal/foetal 
ratio have also been reported (Midgley et al, 1967? Croaignani 
et al, 1972). A much lower value was reported by Faiman et al 
(1968). Amniotic fluid concentrations also show a correlation 
with plasma concentrations and the evidence suggests that values 
are higher in early pregnancy than at term. 
The concentration of hCG in extra-cellular fluid has not 
been reported. Concentration in cerebrospinal fluid (C3F) remains 
substantially lower than the plasma concentration even when plasma 
values have been at a high level for long periods of time. In 
patients with trophoblastic tumours who had no evidence of 
intracranial metastases, the plasma/CSF ratio was between 60/I 
and 600/1 for a wide range of values, with a mean value in excess 
of 200/1 (Bagshawe et al, 1968), There was a significant time 
lag between changes in the plasma concentration and changes in 
the C3F concentration of hCO. 
6. Renal and Metabolic Cleax*ance in Man 
Bioassay estimates of the rate of renal clearance of hCG 
have ranged from 0.18 to 1.19 ml/min (Gastineau et al, 1949). 
Values obtained during the first, second and third trimesters 
of pregnancy by radioimmunoassay were 0.94, 0.66 and 0.85 
(Crosignani et al, 1971). One study found a mean clearance rate 
of 0.36 ml/min by bioassay but a value of 0.70 ml/min by 
L O 
ifflfliunoassay as a r e s u l t of differences between bioassay and 
immunoassay estimates of plasma values (Wide e t a l , 1968), Clearance 
values estimated by radioimmunoassay on more than 100 pa t i en t s 
with t rophoblast ic tumours have been 0.5 to 1,8 ml/min for plasma 
concentrat ions. The plasma and urine concentration of hCG tend 
to be s imi lar when the dai ly urine volume i s about 1-5 l i t e r s 
simply because the clearance ra te approximates 1 ml per min. 
Early studies indicated tha t about 20 percent of an 
intravenously administered preparation of hCG could be recovered 
from the urine (Friedman and Vfeinstein, 1937). Later s tudies 
indicated tha t s imi lar figure was obtained v/hen hOG administered 
i . v , or i.m, to amenorrhoeic women was expected in the urine 
during the succeeding 5 to 6 days (Wide e t a l , 1968). Following 
i . v . in jec t ion, a metabolic clearance ra te of 3.38 for men and 
3.86 for women was found with i n i t i a l f as t component half~lives of 
5.1 hrs and 5.6 hrs and slow component ha l f - l i ves of 23.6 hrs and 
23.9 hrs in men and women respect ively (Rizkallah e t a l , 1969). 
7 . Distr ibut ion and Clearance on Experimental Animals 
When hCG i s administered to another species , the pa t te rn 
of d i s t r ibu t ion and excretion may be influenced by various factors 
which do not operate in man. About 75 percent of hCG administered 
i . v , to rabbi ts was recorded from the urine over a 4 to 24 days 
period using an unspecified immunoassay method (Hisley and 
Fesche, 1966), 
2u 
Administering 3u-labelled hCQ and a-hCG and 3-hCQ subunits 
to immature female rats, Braunstein et al (1972) found biphasic 
plasma disappearance curves with fast and slow components having 
twp times of 141, 6.2 and 11.1 min for the fast phase, and 725, 
58 and 81 min for the slow phases respectively, 
8. HCQ in Neoplastic Diseases 
(i) Trophoblastic and other tumours 
Classical hydatidiform mole is an abnonsal conceptus in 
which there is generally an excess of trophoblast associated with 
hydropic villi and little, if any, foetal tissue proper. Partial 
degrees of mole can also occur. The trophoblast of hydatidiform 
mole or that of normal non-molar pregnancy may given rise to the 
malignant tumour choriocarcinoma. Choriocarcinoma also arises 
in teratomas of the testis and ovary. All these lesions are 
regularly associated with the production of hCG (Masune et al, 
1981J Nishimura, et al, 1981; Amr et al, 1983). The detection 
of hCG in the body fluids of anyone who is not pregnant and who 
has not recently had a hydatidiform mole is indicative of a 
malignant tumour. In the case of patients who have recently 
had a mole, the persistance of hCQ in body fluids for several 
months indicates the presence of either invasive mole or 
choriocarcinoma. Metastatic deposits in the lung of a 27 year 
old women associated with invasive trophoblastic hydatidifona 
mole were detected only with the aid of blood pool subtraction 
d: 
technique using a polyclonal and monoclonal antibody specific to 
hCQ (Morrison et al, 1984). Cancer radioimmunodetection with 
antibodies to hCG and to alpha fetoprotein appear to be a useful 
procedure for the evaluation of patients with testicular cancer 
and can reveal sites of tumour not detected by other methods 
(Javadpour et al, 1980| Begent et al, 1980; Goldenberg et al, 
1981; Wu et al, 1983). 
(ii) Hydatldiform mole 
Zondek (1929) recognised the production of hCG by 
hydatidiform moles and further notable contributions were made 
by Hamberger (1944) and by Delfs (1959). It is widely held that 
hCG values in plasma and urine are greatly increased when mole 
^^ is. s^tu in the uterus. This appears to be true in only half 
of all cases (Campbell et al, 1970).Values within the normal 
pregnancy range are found and in some instances, may be below the 
normal values for that stage of pregnancy. In general the 
concentrations of a-hCG and 3~hCG are much lower than the 
corresponding concentrations of intact hCG. No difference in the 
three groups of patients with complete hydatidiform moles, partial 
hydatidiform mole and non-molar absortions (Smith et al, 1984). 
The risk of choriocarcinoma after mole is about 1000 times higher 
than following normal tenn pregnancy and the risk is largely, 
although not ©topletely, confirmed to the first two years. In 
majority of patients, the trophoblast of hydatidiform mole dies 
out spontaneously but it commonly takes much longer for this to 
d 
to be complete than after normal pregnancy, and molar trophoblast 
may persist for many months as invasive mole (Bagahaii^ , 1969). 
An apparent degree of correlation was observed with tumour activity 
in that case with widespread metastases due to a ooloric carcinoma 
exhibited the highest hCG levels while, in one patient, the level 
of hCQ decreased progressively according to therapeutic response 
(Ayala et al, 1983). A high frequency of immunoactive hCG was 
found in carcinomas of the cervix, breast, gonads and digestive 
system and in malanomaa (Ito and Tahara, 1983j Jacobsen and 
Jacobsen, 1983; Byohkov et al, 1983| Morinaga et al, 1983). 
(iii) Ectopic production of hCG by non~trophoblaatic tumors 
Gonadotropin production by patients with carcinoma of the 
lung was described by Fusco and Rosen (1965). Braustein et al 
(1973) studied detectable levels of hCG in patients with non-
testicular tumors, carcinoma of the stomach, pancrease or breast, 
multiple myloma and melanoma were those most likely to give 
positive response (Goldstein et al, 1974). In patients with 
islet cell tumors, hCG and its subunit were found only in those 
with islet cell carcinoma (Kahn et al, 1977). Hormone production 
was also found in patients with hepatocellular carcinoma 
(Braustein et al, 1973). . 
9. Immunological Properties of hCG 
The intact molecule, free alpha and beta subunits and 
natural fragments of hCG are all immunogenic and antigenic 
2 J 
(Musch et al, 1981| Nieachlag et al, 1982; Stuart et al, 1983). 
Moreover knowledge of the amino acid sequences has made It possible 
to synthesize carbohydrate free replicas of beta-subunlt fragments 
which are both Immunogenic and antigenic (Thanawala et al, 1980| 
Chang et al, 1981 j Caraux et al, 1985; Bellet et al, 1987). The 
properties have been exploited to produce reagents and assays used 
to study the structure function determinants of immunologic and 
biological properties of the hormone (Kofler et al, 1982| 
Furuhashi et al, 1983| Searle et al, 1984). 
Demonstration of partial cross-reactivity of hLH in the 
assay system based upon this particular suggested that it might 
be possible to produce an antiserum which would be less cross-
reactive and therefore capable of distinguishing hCG from hLH, 
hFSH and hTSH in mixtures of these hormones. Such an antiserum 
was identified and a satisfactory assay developed for clinical 
use (Thau et al, 1983). 
The frequency with which antisera specific for hCG and 
p-hCG can be produced is enhanced by immunizing rabbits with a 
conjugate of an appropriate carrier with either natural or 
synthetic peptide consisting of 23 of the 30 carboxy-termlnal 
amlno-aclds unique to the 3-subunlt of hCG (Nash et al, 1980; 
Stevens et al, 1981; Birken et al, 1982; Covey and Laurance, 
1984). Virtually all such antisera distinguish the p-subunit 
of hCG from all other human glycoprotein hormones. 
.ou 
Antigenic potencies of synthet ic pept ides , produced by-
success ively adding appropriate amino acids to the carboxy*-
tenninal amino acid , have been compared (Chen e t a l , 1976). In 
these assay, addit ion of amino acid beyond i t s carboxyterminal 
res idues did not r e su l t in any fur ther enhancement of antigenic 
potency of synthet ic peptides which were equipotent with both 
nat ive and 3-carboxymethylated or S-amidomethylated 0-subunits 
of hCG (Ross, 1977). 
10. Monoclonal Antibodies in Study of Structure Function 
Relationship 
The study of protein structure at all levels proceeds via 
a series of well known technique worked out over the last 20-30 
years (Hirs, 1967). The relationship of protein function to 
protein structure is a rather specialized science as is the 
immunochemical analysis of surface structure on proteins. The 
recent technique of monoclonal antibody production promises to 
have an enormous impact on these three areas of scientific 
research after the initial application being mainly to all surface 
markers (William, 1977j Parham et al, 1982). This is mainly 
because the monoclonal antibodies bind to single specific points 
on the protein antigen and they are available in large quantities 
and invarient quality. These properties combine to make the 
study to protein structure with these reagents much easier. 
Studies on immunochemical analysis of proteins by polyclonal 
antibodies have been reviewed (Cinader, 1967| Amon, 1973; 
Atassi, 1977). A chemical technique to myoglobin elucidate its 
ox 
complete immunochemical structure using polyclonal antisera haa 
been published by Ataasi (1975). 
There have been a number of reporta on the production of 
monoclonal antibodiea to hCQ (Kofler et al, 1982j Moyle et al, 
1982f Chow et al, 1986), Monoclonal antibodies to hCG can be used 
to quantitate hCG in a 2-site sandwich radioimmunoassay 
(Mizuchi et al, 1984), Wada et al (1982) described sandwich 
enzyme immunoassay of hCXJ with solid phase monoclonal antibody 
for the a-subunit and enzyme coupled monoclonal antibody, specific 
for the 3-subunit. Recently capillary tube enzyme immunoassay and 
luminescent immunoassay were used for quantitation of human 
chorionic gonadotropin (Longeon et al, 1986? Nagainis, et al, 1986). 
Totally specific anti-hCG antibodies are directed towards 
an epitope containing amino acids on both a~and 3-subunit but 
spatially arranged so that such antibodies cannot recognize these 
amino acids in the separate subunit molecule (Stuart et al, 1983). 
The production of monoclonal antibodies directed toward hCQ and 
its subunit after immunization with hCO (oupta and Talwar, 1980; 
Stahli et al, 1980) and its 0-subunit (Ehrlich and Canfield, 1982; 
Khazaeli et al, 1981) have also been reported. Monoclonal 
antibodies against each subunit have mapped the relative binding 
sites of several monoclonal antibodies that react with intact 
hCG using a solid phase assay (Moyle et al, 1982, 1983). 
One of the essential advantages of MAb compared to 
conventional polyclonal antisera is certainly their monospecificity 
u u 
for a particular antigenic determinant on a complex molecule. 
Noverthleas, it is obvious that in situation \riiere the recognized 
determinant is present in the identical or conformationally 
similar form on different molecule, a 'true' immunological cross 
reactivity will be revealedi, However, in determining the 
quality and possible application of an antibody preparation the 
antibody affinity must be atleast equally as iaportant as the 
specificity. Since the affinity is directly related to the 
sensitivity of the test system in vAiich the antibody will be 
used. This holds true for most hormone determinations using 
immunological techniques where apart from high specificity, high 
sensitivity is required due to the low concentrations of the 
compounds investigated (Berger et al, 1984). 
11. Immunological Properties of p-Subunit of hCQ 
The a-subunit of the horiBone is chemically identical to 
the a-subunits of such hormones as LH, hFSH and hTSH which are 
circulating continuously in the body. Isoimmunization with hCG 
results in the production of antibodies which cross react with 
all these hormones, leading to severe endocrinological distur-
bances (Stevens, 1983; Stevens and Crystle, 1973) and the danger 
exists of possible immunopathological changes in susceptible 
organs, particularly the pitutary. The 0-subunit of these 
hormones are different and confer biological activity (Canfield 
et al, 1971; Pierce et al, 1971a). A fertility regulation 
vaccine based on the jS-subunlt of hCG would therefore seem a 
more promising proposition. Several investigator have used this 
approach in a variety of animal species including baboons, 
marmosets, Rhesus monkey, sheep and rabbits (Stevens, 1975I 
Heam et al, 19751 Stevens 1975j Talwar et al, 1976a) and in 
women (Talwar et al, 1976bj Nash et al, 1980| Shahani et al, 
1982). However, although immunization with 3~hCG results in the 
production of a good response in terms of amount and affinity 
of antibodies against hCG, cross-reactivity with hLH is still 
present (Thanwala et al, 1978). 
The antigen used in the vaccine was limited to the 
0-8ubunit of hCG to minimized the cross-reactions of antibodies 
with other glycoprotein hormones. It was hoped that linking the 
3-subunit to a foreign protein would render it antigenic to the 
human being. Tests of a 3-hCG-TT vaccine in human showed to 
stimulate antibodies against hCG but the titers were relatively 
low and transient in some of the test subject (Talwar et al, 
1976b| Nash et al, 1980| Shahani et al, 1982). 
Initial trials of such a vaccine in women (Nash et al, 
1980) showed that antibodies capable of neutralizing the biologi-
cal activity of hCO were produced but the titers varied consi-
derably among individuals and in some women were very low. It 
was therefore deemed necessary to increase the antigenic response 
by adjuvants. The efficacy of alternative protein and 
carbohydrate carriers and of the muramyldipeptide family of 
adjuvants is effecting increased antibody response in an animal 
test system has been reported (Tseng et al, 1985| Nash et al, 
1985). The effectiveness of adjuvants in increasing antibody 
o't 
response In rabbi t s to vaccination with the 3-"3ubunit of hCG 
l inked to tetanus toxoid (Nash e t a l , 1985j Chang e t a l , 1983) 
have been reported. Several ad;Juvants including some analogs 
of muramyl dipeptide and a streptococcal preparat ion OK 432 
Increased antibody t i t e r to 3-10 folds (Laurence and Covey, 1984| 
Change e t a l , 1986). But the vaccine consist ing of the 0-subunit 
of hCa linked to TT and adsorbed on Al(OH), suggested tha t the 
magnitude and duration of the antibody response were not adequate 
to prevent pregnancy in some women (Nash e t a l , 1980| Shahani 
e t a l , 1982). 
Corynebacterium parviwa was compared with freund's complete 
adjuvants for potent ia t ion of the rabbi t immune response to 
3~subunit linked to tetanus toxoid. With each adjuvant, ant ibodies 
t o hCO were detected using passive hemagglutination. Higher 
antibody t i t e r were produced by FCA t rea ted animals (Covey and 
Laurence, 1984). 
12. C-Tterminal Peptide of 0-Subunit of hCG 
Antisera ra ised against the en t i r e 0-3ubunit of hCG usually 
c ross - reac t to some extent with human LH. While t h i s degree of 
cross- react ion in serum assay can be r e l a t i v e l y minor, human LH 
becomes a g rea te r source of e r ro r when urine specimens are 
concentrated for measurement of very low levels of hCG secre t ion . 
To circumvent t h i s problem peptides from the unique 3-COQH-
terminal region can be employed as immunogen to e l i c i t an t i sera 
of g rea te r spec i f i c i ty for hCG, The use of 3-carboxy terminal 
peptide as iaimunogen with the full complement of carbohydrate 
that have given rise to antisera of improved sensi t ivi ty for 
hCO detection has been reported (Birken et a l , 1982). 
The specific biological act ivi ty of highly purified hCG 
was determined by a ventz^l prostate weight bioassay before and 
af ter incubation with an antiserum to a COOH-terminal peptide 
unique to the 0-subunit of hCG (Louvet e t a l , 1974), Although 
the antibody was shown to bind hCG, the antibody hormone complex 
retained the biological act ivi ty of the native hormone. The 
author have reported that immunization with the COOH-terminal 
polypeptide region of the P-subunit does not necessarily stimulate 
production of neutralizing antibodies (Louvet et al» 1974). While 
the non-cross reactive monoclonal antibodies to hCG were prepared 
af ter immunization with a conjugate of synthetic peptide to 
diphtheria toxoid (Caraux e t a l , 1985). 
^ t in a study, a peptide fragment analogous to the 
amino acid sequence of the carboxyl tenainal 45 residues (101-145) 
of the 0-hGG with a-aminobutyric acid substituting for cysteine 
a t position 110 was synthesized. Antisera raised against this 
conjugate was found to bind with hCG but did not cross-react 
with hLH in radioimmunoassay (Chang et a l , 1981). Most importantly, 
th i s antisera effectively neutralized t te biological act ivi ty 
of hCG as deteimined by ra t uterine vi«ight assay. Similarly 
lack of cross-reactivity of the antibodies against a synthetic 
37 amino acid C-terminal peptide of 3-hCO conjugated to 
tetanus toxoid as carr ier with hCG was determined by direct 
0 0 
binding in RIA and by immunofluortscence assay on adult human 
pituitary secretion (Thanwala et al, 1980). 
13. Interaction of Purocoumarins with Proteins and Enzymes 
The furocoumarins, also referred as psoralens, belong to 
a group of heterocyclic compounds formed by the condensation of 
coumarin and furan ring* Many natural and synthetic furocou-
marins have been made in the laboratory (Scott et al, 1976). Of 
these furocoumarins, psoralen, 8-methoxyp3oralen and 4,5»8-
trimethylpsoralen are used clinically in the treatment of vitiligo 
and have been extensively investigated in terms of their thera-
peutic usefulness, photosensitivity and melanogenic properties 
(Fowlks, 1959J Kaufman, 1960| Scott et al, 1976). 
The beneficial effects of the combination of psoralen 
plus 365 nm light (PUVA) in the treatment of skin diseases such 
as psoriasis control excess cell division in the skin by virtue 
of its ability to damage IMA» Such lesions in DNA thus lead to 
inhibition of DNA synthesis, erythema production and increased 
skin pigmentation as well as mutation and killing of bacteria, 
chromosome aberrations, inactivation of viruses and inhibition 
of tumour transmitting capacity of certain tumour cells. In 
addition to damage to I^A, PUVA treatment may also cause damage 
to proteins. Lens proteins are particularly susceptible to this 
type of damage since psoralen-protein photoadducts may be perma-
nently lodged within the lens (Lerman and Brokman, 1978| 
Lerman et al, 1980). Apart from the photobiological consequences 
o / 
of PUVA treatment, the photolabelllng of bioaiolecules with 
prosalens provides a r e l a t i ve ly new tool for probing biopolymer 
s t ructure(Hal l ick e t a l , 1978| Nasa, 1979J Shen and Ifearst, 1979J 
Song and Ou, 1980), 
As with DNA, psoralen form complex with p ro te in . Several 
s tudies have concerned the in te rac t ion of furocoumarins with 
prote ins (Tal ib, 19751 Veronese e t a l , 1978? 1979? 1981), so as 
t o understand t h e i r role in the biological a c t i v i t y of furocou-
marins. The strong non-covalent binding in the dark between 
furocoumarin and albumin suggests a possible influence of plasma 
prote ins in the pharmacokenetic behaviour of these drugs 
(Veronese e t a l , 1978). 
The associa t ion constants of psoralen with human serum 
albumin are s imi lar to those with DNA (Artuc e t a l , 1979| 
Veronese e t a l , 1979). The a b i l i t y of 8-methoxypsoralen (8-MOP) 
to bind with human serum albumin has been invest igated 411 v i t r o 
through equilibrium d ia lys i s and fluorescence quenching 
experiments (Veronese e t a l , 1978). 8-MOP also form a covalent 
conjugate with bovine serum albumin possibly with ty ros in 
resideues by UVA i r r ad ia t ion under a i r . There i s apparantly 
no observable react ion between 8-MOP and tryptophan when the 
mixture in solut ion i s i r rad ia ted in the absence of oxygen 
(Lerman e t a l , 1980). In the presence of oxygen, however, the 
loss of aromatic type hydrogen atoms a t the 3\ ^* and 4 ' , 5 ' 
pos i t ion of 8-MOP and a t the indole Cg posi t ion of tryptophan 
O O 
has been shown (Megaw et al, 1980} Megaw and Lerman, 1980). No 
explanation was offered to account for the effect of oxygen, but 
a mechanlam similar to that given for the photobinding of S-MOP 
to proteins could be expected to prevail (Yoshikawa et al, 1979). 
In the latter work, it was demonstrated that the product formed 
in the reaction between 8-MOP and singlet oxygen readily add in 
the dark to bovine senim albumin to form a covalent conjugate. 
In the same study,it was also observed that some other form of the 
conjugate was produced via an oxygenr-independent pathway and 
therefore, direct photoaddition of 8-MOP triplet state of the 
protein was proposed. In some studies, it is indicated that 
following UV-A irradiation, proteins may be modified since 
enzymes may be inactivated by the photodynamic action of 8-MOP 
probably via singlet oxygen production (Poppe and Grossweiner, 
1975; Veronese et al, 1979) and covalent photoaddition of the 
furocoumarin to protein was observed (Yoshikawa et al, 1979| 
Lerman et al, 1980). 
In the present study, commercial sample of hCO has been 
purified to homogeneity by column chromatography. The effect 
of UV irradiation on hCG has been investigated by spectroscopic 
methods, Xryptic digestibility, urea denaturation, lysine 
modification of hCQ and its modified form along with immunological 
characterization of its induced antibodies have also been 
investigated. Dark interaction of psoralen with hCG and its 
a and 3 subunits was carried out by fluorescence quenching 
technique. The validity of this technique is supported by the 
U --!' 
fac t tha t in te rac t ion s tudies using fluorescence quenching and 
equilibrium d ia lys i s technique yields e s s e n t i a l l y the same r e su l t s 
(Romeu e t a l , 1976). The spec i f i c i ty and c ros s - r eac t iv i ty of 
t h e i r induced antibodies have been invest igated by ELISA, 
Different peptides of 3-8ubunit were i so la ted by chymotrypsin 
d iges t ion . These were seperated and purif ied by column chromato-
graphy and pr i l iminary studies ident i f ied the react ive fragement(s)» 
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E X P E R I M E N T A L 
(A) MATERIALS 
Proteins 
Human chorionic gonadotropin (hCO), bovine aerum albiamin, 
a-chymotrypsin and trypsin were obtained from Sigma Chemical 
Company, U.S.A. 
ChamioaXs for Polymcryianide del Sleotrophoresls 
Acrylamide and Coomaasie br i l l i an t blue R were purchased 
from Sigma Chemical Company, U.S.A. NNN'N'-tetramethylethylenedi-
amine, sodium dodecyl sulfate and ammonium persulfate were the 
product of B.D.H. England. Bisacrylamide was from Reanal, I&ingary 
and 3'-me reap toe thanol was purchased from Calbiochem, U.S.A. 
Chemicals for Immunization 
Chromatographically pure psoralen was a gift from Central 
Drug Research Institute, Lucknow, and Freund's complete adjuvant 
was obtained from Difco Chemical Company, U.S.A. 
Chemicals used in Enzyme Linked Immunosorbent Assay 
Qoat anti-rabbit IgG alkalibe phosphatase conjugate was 
purchased from Sigma Chemical Company, U.S.A. p-nitrophenyl 
phosphate was from C.3.I.R. Centre for Biochemicals, Delhi. 
Diethanolamine was from B.D.H. India. Tween-20 was from Koch-
light Laboratories* England, and sodium azide was obtained from 
4i 
Polskie, Poland. Polystyrene flat bottom plates having 96 wells 
were purchased from Cooke Mioi*otiter Company, U»S.A. 
Hlsoellaneous Chemicals 
Agarose and 2,4,6-trinitrobenzene sulfonic acid were 
purchased from Sigma Chemical Company, U.S.A. Sephadex G~100, 
G-50, Q-25» Blue dextran-2000, Sepharose 4B were obtained from 
Pharmacia Fine Chemicals, Sweden. Ninhydrin was from B.D.H. 
England. DSAE-cellulose was obtained from Whatman, Ezigland and 
cynogen bromide was from Sisoo Research Laboratories, Bombay. 
All other diemicals used were of highest analytical grade. 
Irradiation Source 
Short wavelength ultraviolet lamp, Spectrollne (Model R-51» 
Black Light Eastern Xno, U.S.A.) having maximum emission a t 254 nm 
and long wavelength ultraviolet lamp, Spectroline (Model B-IOOi 
Black Light Eastern Inc, U.S.A.) having maximum emission a t 365 nm» 
were used as the source of radiant energy. 
Light Absorption Measuremtnts 
Spectral properties of proteins in UV and visible region 
were studied using Beckman Dlf-6 spectrophotometer with quartz 
cuvette of 1.0 cm path length. The fluorescence studies were 
conducted on Aminco-Bowman spectrophotofluorometer equipped with 
Xenon lamp as excitation source. 
4^. 
pH m»asurttm«nts 
The pH was measured on an Ellco pH meter model LI-10T 
(Electronics,Corporation, Hyderabad, India) with Elico glass 
and saturated oalomal e lec t rodes . 
(B) METHODS 
1, Purification of Human Chorionic Gonadotropin 
The commercial samples of human chorionic gonadotropin 
obtained from Sigma Chemical Company, U.S.A. showed heterogeneity 
in polyacrylamlde gel electrophoresis. The hormone was purified 
by gel filter^tion. 
2. Qel Filteration Chromatography 
Preparative gel filteration chromatography was performed 
on Sephadex Q-100 column (1.8 cm x 66.0 cm) equilibrated with 
0.05M phosphate buffer pH 7.5 containing 0.02 percent sodium 
azide. Commercial human chorionic gonadotropin (20-25 mg/ml) 
was applied to the column and eluted with equilibrating buffer 
at a flow rate of 20 ml/hr in 3.0 ml fractions. The fractions 
were monitored from protein at a wavelength of 280 nm. The peak 
fractions were pooled, concentrated and dialyzed against the 
same buffer. 
3* Polyacrylamidie Qel Eleotrophoresis 
The purity of human chorionic gonadotropin was checked by 
native polyacrylamide disc gel electrophoresis (Laemmli, 1970). 
-io 
(a) Buffers and other reagents used were as followst 
(i) Aorylamlde solution (30% acrylamlde and 0.®6 bioacrylamide) 
(ii) Lower Tris (0.37M Tris pH 8,8 adjusted with 6 N HCl) 
(iii) Upper Tris (0.062M Tris, pH 6,8, adjusted with 6 N HCl) 
(iv) Reservoir buffer (Tris-glycine, pH 8,3) 
(v) Sample buffer (upper Tris buffer contains 1M auorose) 
(vi) Staining solution {0,25% Coomassie Brilliant Blue, 
25% methanol and 10% acetic acid) 
(vii) Destaining solution (20% methanol and 7% acetic acid). 
The stock acrylamide solution was diluted to a 7,5 percent 
concentration for resolving gel (0,6 cm x 15 cm in Lower Tris) 
and to a 3 percent concentration for the stacking gel (0.6cm x 3cm 
in upper Tris), Protein samples were prepared in upper Tris 
containing 1M sucrose and 0.005 percent bromophenol blue as 
tracking dye. Usually 100 Mg of protein v^s eleotrophoresed. The 
electrophoresis was performed at 1mA/gel during the first hour of 
stacking and 2mA/s®i until the tracking dye reached the bottom 
of the gel (5-6hr), The gels were removed and set into staining 
solution and thereafter destained in destaining solution, 
Subunit composition of hCG was determined by SDS-
poljracrylamide gel electrophoresis (Laemmli, I960). 
4. Separation of Subunits of Human Chorionic Gonadotropin 
Separation of subunits was done by two different methods, 
(i) Subunits were separated using the method of Canfield et al, 
(1970). Purified hCG was incubated in 3.0 ral of 10M urea in 3mM 
- i t 
sodium borate/TfflM sodium phosphate pH 8.0 for 24 hrs a t room 
temperature. After incubation the sample was applied onto a 
column of DEAE-cellulose previously equi l ib ra ted with bora te / 
phosphate buffer . Alpha subunlt of hCG (ahCG) was not retained 
by the column and therefore eluted with equ i l ib i^ t lng buffer. 
Whereas beta subunit (3hC0) was eluted with equ i l ib ra t ing buffer 
contains 0.1M NaCl and 5M urea. 
( i i ) An other method of separation of subunita was the method 
of Swaminathan and Bahl (1970). Brief ly , the d issoc ia t ion of 
hCO in to two subunits was effected by 8M urea. A aample of 
pur i f ied hCQ (11,9mg) was dissolved in0»1 ml of 8M urea in 0.04M 
Tris-phosphate buffer pH 7.5 and incubated a t 37°G for 60 min. 
The incubation mixture was di luted in 0.25 ml with the above 
buffer and t ransferred to a column of DEAE-cellulose (0-9cm x 30cm), 
p re-equi l ib ra ted with 0.04M Tris-phosphate buffer, pH 7.5* The 
column was developed with a s a l t gradient (0.0 to 0.2M NaCl in 
0.04M Tris-phosphate buffer pH 7.5) and two prote in peaks, 
designated as A and B, corresponding to a and $ subunits ^ r e 
obtained (F ig ,3 ) . The peak fract ions were pooled, concentrated 
and exhaustively dialyzed against buffer. 
5 . Ul t raviole t I r rad ia t ion of hCQ 
The hormone in 0.05M phosphate buffer^pH 7.5 was i r r ad ia t ed 
with 254nm l i g h t . The solut ions were i r r ad ia ted in small beakers 
placed in a water cooled container (Asif e t a l , 1969)» I r r ad ia t ion 
was carr ied out a t a eonatant temperatura of a s ' c + 1°C. 
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Fig.3. Separation of hCG subunits by DEAE cellulose chromatography. 
The hormone was dissolved in 8M urea in Tris-phosphate 
buffer, pH 7.5 and incubated at 37°C for 1 hr. The sample 
was loaded onto a Column (0.9x30cm) of DEAE cellulose and 
the bound material was eluted with a linear gradient of 
0.0 - 0.2 M NaCl. Fraction size : 3.0 ml; Flow rate: 20 ml/hr. 
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6. UV Sipeotral Properties of hCG 
The light absorption characteristics of native and 
irradiated hCG in UV region were studied on Beckman DU-6 
spectrophotometer. The honaone samples (500 Mg/ml) were filtered 
through Milllpore filter, prior to the spectral studies. 
7* Fluorescence Spectral Studies 
The intrinsic fluorescence of native and irradiated hCO 
were monitored in 0.05M phosphate buffer, pH 7.5» The protein 
was excited at 280 nm for the measurement of fluorescence from 
tyrosine residues. All the fluorescence studies w r e performed 
on uncorrected spectra. 
8. Chemical Modification of Amino Groups of hCG 
The modification of amino groups of hCG with trinltro-
benzene sulfonic acid (TNBS) was performed according to the 
method of Plapp etaL(1971). Briefly the protein (2 mg/ml|native/ 
irradiated) was dissolved in borate buffer (0.05M NagB^O-jpH 9.5) 
and a fresh solution of 0.02M TNBS in water was prepared. The 
reaction was initiated by the addition of 0.1 ml of TNBS solution 
to 1.0 ml of protein solution. The reaction kinetics was followed 
by monitoring the absorbanoe at 367 nm. The extent of trlnltro-
phenylatlon of hCO was monitored directly in the reaction mixture 
4 -1 -1 by assuming a molar extinction coefficient of 1.1 x 10 M cm 
for the trinltrophenyl group. 
'ti 
9. Sfftot of UV Radiation on the Limited Proteolysis of hCG 
The tryptic digestibility of native and irradiated hCO 
was carried out by the method described by Paik and Kim (1972) 
with some minor modifications. The method involves quantitation 
of free amino groups exposed as a result of prot«olysi3. For 
the detennination of free amino groups* the procedure described 
by Moore and Stein (1948) was followed. 
(i) Crystallization of ninhydrin 
10 gm of commercial ninhydrin powder was dissolved in 
150 ml of hot water. The hot solution was stirred with 10 gm 
of activated charcoal and filtered. The fliterate was left at 
4°C for 72 hra. The crystals were washed with ice cold water and 
dried over phosphorus pentaoxide in a vacuum desiccator. 
(11) Ninhydrin reagent 
800 mg of ninhydrin was dissolved in 20 ml of methyl 
cellosolve and mixed with 20 ml of 0.2M sodium citrate buffer, 
pH 5.0, followed by the addition of 0.68 ml of 9.8 percent 
stannous chloride suspension in citrate buffer. The reagent was 
prepared fresh before use. 
(Hi) Procedure 
To 3.0 ml of hCG (400 Mg/ml in 0.5M phosphate buffer, 
pH 7.2) preincubated for 10 minutes at 37**C was added equal volume 
of trypsin (400 Mg/ml in 0.5M phosphate buffer, pH 7.2). The 
'i 5 
contents were mixed and Incubated a t 37*^0. At knowa intervals 
of time, 0.5 ml aliquota of the digestion mixture vere quenched 
and mixed with 0.5 ml of 0.2M chilled c i t ra te buffer, pH 5.0. 
To 1,0 ml of chilled reaction mixture was added 1.0 ml of 
ninhydrin reagent and the samples were heated on a boiling water 
bath for 15 minutes. The tubes were cooled in ice water and 
5.0 ml of 50 percent ethanol was added to each tube. Absorbance 
of the sample was recorded at 570 nm. The number of free amino 
groups exposed after tryptic hydrolysis of hCG was computed from 
~7 "-7 
a standard curve dr^wn with isoleucine (0.7x10 to 3.8x10 moles). 
10. Colorimetric Method for the Detenaination of Reducing 
Sugars in hCQ 
Determination of sugar contents in native/irradiated hCG 
was done by the method of Dubois et a l (1956). 1.0 ml of hCQ 
solution was mixed with 1.0 ml of freshly prepared 3% phenol. 
Five ml of cone, fiUSO. was added rapidly. The stream of acid 
should be against liquid surface rather than side of the tes t 
tube in order to obtain good mixing. Tubes were allowed to 
stand half-an-hour a t room temperature. Color was stable for 
several hours. Absorbance of characteristic yellow-orange color 
was measured at 490 nm for hexoses. Blanks were prepared by 
substituting d is t i l l ed water in l ieu of hCG. 
10. Immunization 
All rabbits were bled before receiving initial in^Jection 
in order to obtain a supply of preimmune rabbit serum. Rabbits 
(9-12 months old, weighing 1.0 to 1.5 kg) were immunized with 
antigen suspended (nativt/ irradiated hCO)in Freund»s complete 
adjuvant by intramuscular injection in hind leg, weekly for 
three weeks. Each animals received 100 Mg of antigen per injection. 
Blood was collected at weekly intervals by heart puncture. Sera 
were separated and stored at -4°C, 
12. Immunological Studies 
( i ) Immunodiffusion (ID) 
The precipit in reactions were performed by Ouchterlonu 
double diffusion in 0A% agarose. 
5-6 ml of molten agarose (0.4% in PBS containing 0.1 
percent sodium azide) was heated to boiling, f i l tered and poured 
into glass petr i dishes (50mm x 15mm) and allowed to harden at 
room temperature. Walls having a diameter of 5 mm were cut in a 
typical seven well pattern. The pe t r i dishes were stored a t 
4°C. 
50 Ml of ser ia l ly diluted antisera were placed in per i -
pheral wells and antigen in the central well. The diffusion of 
antigen and antisera in agarose gel was allowed for 24-48 hrs 
in a moist chamber a t room temperature. 
(li) Counterimmunoeleotrophoresis (CIE) 
CIB was carried out in 0 . ^ agarose using microscopic 
sl ide (Kurata and Tan, 1976). Three ml of 0.6 percent agarose 
(in 0.025M barbital buffer, pH 8.4 containing 0.1 percent sodium 
uU 
azide) was pipet ted and spread unlfonnly onto a clean mlcrosooplo 
s l i d e (25iBm x ZOnun) and allovrad to so l id i fy a t room temperature. 
The s l ides were stored in a moist chamber a t 4^C and used within 
three days* 
Antigen was placed in cathodal wells and an t i se ra in 
anodal wells (20 Ml in each we l l ) . Electrophoresis was performed 
in 0.05M barb i ta l buffer, pH 8.4 with a current of 3-4 mA per 
s l i d e for 30-50 minutes. Non-specific p r ec ip i t i n l i n e s were 
abolished by washing the s l ides with 5 percent sodium c i t r a t e 
so lu t ion . The s l i des were examined v i sua l ly for p r e c i p i t i n 
l i n e s and the r e su l t s rscordted. 
13 . Bnzymft Linked-Immtmosorbent Assay on Polyst3rrene Pla tes 
(a ) Buffers and other reagents 
( i ) Bicarbonate buffer (coating buffer) 
0.015 M sodium carbonate 
0.035 M sodium bicarbonate 
0.02 percent sodium azide 
pH adjusted to 9.6 
( i i ) Saline Tween-aO (3T-20) 
0.15 M sodium chloride 
0.05 percent Tween-20 
pH ad^justed to 7.0 
01 
(ill) Diethanolamine buffer (DBA buffer) 
1M diethanolamine 
0.1 mg/ml magnessium chloride 
0.02 peroent sodium azide 
pH adjusted to 9.8 with HCl 
(iv) Substrate (PNP-P) 
-3 5x10 M p-nitrophenyl phosphate in diethanolamine 
buffer. 
(b) Procedure 
Technique of Voller e t a l (1976) with some modifications 
was used for the detection of antibodies. Hormone in coating 
buffer (iMg/0.25 ml/well) was added to the wells of microtiter 
p la te . The plates were incubated for 2 hrs at room temperature 
and then a t 4°C overnight. The wells were washed 3 times with 
ST-20 and unoccupied s i tes were f i l led with 1.0 percent BSA in 
ST-20 by incubating the plate a t 4°C overnight. After washing 
the plate with ST-20, 0.25 ml of ser ia l ly diluted serum in 
3T-20 was added. The plates were incubated for 1 hr a t 37°C, 
washed with ST-20 and 0.25 ml of thousand time diluted an t i -
rabbit IgG alkaline phosphatase conjugate was added. At the end 
of 2 hrs incubation a t 37°C, the plate was emptied and washed with 
ST-20 thrice followed by one washing with d i s t i l l ed water. 
Substrate solution (PNP -P, 0.25 ml) was added. The plate was 
incubated a t 37°C for 1 hr and the reaction was stopped by the 
addition ot 0.05 ml o£ 3N NaOH. The contents of each well were 
Oli 
read a t 400 nm. Results were expressed as ^ ^ +.- ^control* 
14. IiamunohistoXogioal Studies 
( i ) Imaunization of r a t s 
Male ra ta (weighing 50-60 gm) were injected 
in t r ape r i tonea l ly with 100 Mg of na t ive / i r r ad ia t ed hCO on 
a l t e rna t ive days. After 4 in45ections the animals were sacr i f ied 
and t e s t e s were removed. 
( i i ) Histology 
For histological studies, testes were fixed in Bouin's 
(alcoholic) solution for 24 hrs and washed several times with 
70?i alcohol. These were later taken through different grades of 
alcohol and cleared in xylene, infilterated with 50J50 of wax 
and xylene and finally embedded in pure paraffin (50-60*^C). 
Section of 5-7M thickness were cut by rotatry miorotou.e and 
stained with heamotoxylin and counter stained with eosin. The 
stained sections were dehydrated and cleared in usual manner and 
mounted in DPX. 
15, Dark Binding of Psoralen to hCG 
Fluorescence intensity of psoralen was studied in 0.05M 
phosphate buffer, pH 7.4 containing 0.9 percent sodium chloride 
(Veronese et al, 1979). The excitation and emission wavelengths 
of psoralen obtained from the ifluorescence spectra were found 
to be 330 nm and 450 nm respectively. The interaction of 
o O 
psoralen with hCQ was investigated by monitoring i t s in t r ins ic 
fluorescence in free and bound (hCO-paoralen complex) states 
af ter incubating i t in dark for 24 hours a t room temperature. 
The difference in fluorescence intensi t ies of the drug in the 
above two states (fluorescence quenching) was assumed to be 
proportional to the amount of hCG bound drug. 
16. Fluorescence Transition of hCQ in 8M \Jr%& 
0.5 ml of hCO (1 fflg/ml in 0.05M phosphate buffer^pH 7.4) 
and 2.0 ml of 10M urea were mixed to give a f inal concentration 
ot hCG as 200 Mg/ffil and that of urea 8M. Fluorescence intensity 
was recorded a t 360 nm (excitation wavelength 280 nm). The 
fraction of hCG in denatured state was calculated using the 
following expression (Tanford, 1968), 
° (F)D - (F)N 
where (F)„, (F) . and (F)_ represent the fluorescence intensi t ies 
H 0D8 u 
in native, observed and denatured states respectively, 
17. Gel Filteration 
Dark binding of psoralen to hCG was also studied by gel 
filteration chromatography. Native hCO and hCG~psoralen complex 
were chromatographed on Sephadex G-100 c-olumn (1.8 cm x 66.0 cm) 
and eluted with 0.05M phosphate buffer. pH 7.4 containing 0.9% 
NaCl. 2.0 ml fractions were collected at a flow rate of 
18 ml/hr. 
u t 
18• Immunization 
Rabbits were immunized with the complex of psoralen with 
hCG and i t s a and ^-subunits suspended in Freund's complete 
adjuvant by intramuscular injection weekly for three weeks. 
Blood was collected at weekly intervals by heart puncture. Sera 
were separated by centrifugation and stored a t -4®C unt i l use, 
19, Antibody Evaluation in Sera by ELI3A 
Preimmunized and immunized rabbit sera a t different 
dilutions were tested by ELI3A. Wells of polystyrene plate 
were coated with hCQ (lMg/well in coating buffer) as described 
ea r l i e r . The react ivi ty of induced antibodies was checked by 
making a series of serum dilut ions. The enzyme act ivi ty in 
conjugate was monitored with p-nitrophenyl phosphate a t 400 nm 
and results were expressed as A g^gt*" \ o n t r o l * 
20. Determination of Protein Concentration 
Protein was estimated by the method of Lowry e t a l (1951) 
asdescribed belowi 
(a) Preparation of Folia-phenol reagent 
The Folin-phenol reagent was prepared by the procedure 
given by Folin and Ciooalteu (1927). 100 gm of aodiuffl tungstate, 
25 gffl of sodium molybdate, 700 ml of d is t i l l ed water, 48.2 ml of 
85 percent orthophosphoric acid and 100 ml of hydrochloric acid 
were refluxed in dark for 10 hrs. 128 gm of lithium sulfate, 
u J 
50 ml of d i s t i l l e d water and few drops of bromine were added 
t o the mixture. Excess bromine was removed by boil ing the 
mixture for 15 minutes. The solut ion was cooled, d i lu ted to 
one l i t e r and fi l tejred. The bright yellow reagent was protected 
from l i g h t by s tor ing i t in amber colored b o t t l e . Tte above 
reagent was di luted four times with d i s t i l l e d water before use. 
(b) Alkaline copper reagent 
The components of a lka l ine copper reagent were as follows: 
( i ) 2 percent sodium carbonate in 0.01M sodium hydroxicte. 
( i i ) 0.5 percent copper sulfate in 1 percent sodium potassium 
t a r t a r a t e . 
50 ml of ( i ) was mixed with 1.0 ml of ( i iXThe reagent 
was prepared fresh before use, 
( i i i ) Procedure 
1.0 ml of protein sample was mixed with 5.0 ml of alkaline 
copper reagent. The tubes were kept for 10 minutes at room 
temperature and 1,0 ml of diluted Folin-phenol reagent was added. 
The contents were mixed immediately and allowed to stand for 
30 minutes at room temperature. The absorbance was read at 
660 nm. Concentration of unknown samples were computed from a 
standard plot drawn by using bovineserum albumin. 
21. Isolation of IgO 
IgG from preimmune and immune sera was isolated by DBAE 
cellulose absorption method of Stanworth (i960).IgG was isolated 
yj V 
also from crude immunoglobulins by DEAE cellulose chromatography. 
(a) Isolation of IgQ by QSAB cellulose adsor|)tion method 
Approximately 17.0 gm of moist DEAE cellulose previously 
washed and equilibrated with 0.01M sodium phosphate buffer 
containing 0.015M NaCl, pH 7.5 was mixed with 2.5 ml of cold 
phosphate buffer, 2.5 ml of serum (previously dialyzed for 
18 hr at 4 C against phosphate buffer) was added dropwiae to the 
exchanger with continuous mixing. The mixture was kept for 
5 hr at 4°C. Thereafter, 5.0 ml of cold buffer was added with 
stirring* The resulting slurry was centrifuged in cold for 
15~20 minutes. The supernatant containing IgG was decanted and 
cleared from cellulose, if any, by recentrifugation. The purity 
of the isolated IgO was checked by polyacrylamide gel electro-
phoresis using 10 percent gel. 
(b) Isolation of IgG by DBAE Cellulose Chromatography 
(i) Preparation of crude immunoglobulins 
3.0 ml of 100 percent saturated am?|onium sulfate solution 
was slowly added to 5.0 ml of serum in cold with occassional 
shaking and the mixture was kept at 4**C for 2 hr for complete 
precipitation of the immunoglobulins. The precipitate was 
recovered by centrifugation and washed thrice with 37 percent 
saturated ammonium sulfate solution. The washed precipitate 
was dissolved and dialyzed against 0.01M phosphate buffer, 
pH 8.0 
u i 
(11) DSAE cellulose chromatography 
Dlalyzed crude Immunoglobulins were loaded onto a column 
of lEAE cellulose (2om x 20cm) previously equilibrated with 
starting buffer (O.OIM phosphate buffer, pH 8,0). The column was 
eluted at room temperature with linear ionic strength gradient 
of 0.01M-0.3M phosphate buffer, pH 8.0. 3.0 ml fractions were 
collected and monitored for protein (Fig,^), First peak of the 
chromatogram was pooled and used as purified IgG. 
22. Binding of Psoralen to hCQ by BLISA 
Plates were coated with hCG (lMg/well in bicarbonate 
buffer) overnight at 4°C. Wells were washed with ST-20 and 
unoccupied sites were filled with B3A {^% in Sf-20). Psoralen 
(10 ng to 100 ng in ST-20) was added prior of the addition of 
antibodies. After addition of psoralen, plate was incubated in 
dark for 24 hours. ELISA was performed as described earlier. 
23. Interaction of Psoralen to hCO in Presence of UV-A Light 
Ultraviolet irradiation was carried out at room 
temperature. A long wavelength ultraviolet lamp having maximum 
emission at 365 nm was used as the source of radiant energy. 
3.0 ml aqueous solution of hCG (100 Mg/ml) in 0.05M phosphate 
buffer containing 0.9% NaCl, pH 7.4 in the presence of psoralen 
(2-10 Mg/ml) was irradiated at a distance of 7.0 cm from the 
lamp for different time periods. After irradiation, their 
fluorescence intensities were recorded at emission, maxima of 
psoralen. 
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Fig.4. Isolation of serum IgG by DEAE cellulose chromatography. 
Thirty seven persent saturated ammonium sulfate 
precipitated serum fraction was used for isolation of 
IgG. The elution was performed by applying a linear 
ionic gradient of 0.01M - 0.3M phosphate buffer, pH 8.0. 
Fractions of 3.0 ml were collected and monitored for 
protein. 
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24» Dark In terac t ion of Psoralen to Alpha and Bttta Subunita of 
hCG 
Fluorescenoe spect ra l proper t ies of hCG subunits and 
psoralen were studied in 0.05M phosphate buffer,pH 7.4 containing 
0.9 percent NaCl, The extent of in te rac t ion between psoralen and 
subunits of hCG was evaluated as described e a r l i e r , Subunits 
binding to psoralen was also studied by ge l f i l t e r a t i o n on 
Sephadex G-100 as described e a r l i e r . 
25 . Chymotrypain Digestion of Beta-Subunit 
Chymotrjrpsin digestion of ^-subunit was done by the 
method of Carlsen e t a l (1973). Briefly the method was as 
followst 
( i ) Carboxymethylation of P-hCG 
To 10 fflg of 3-subunit in 3.0 ml of 8M urea, 0.5M Tris and 
0.001M EDTA, pH 8 . 1 , was added 30 mg d i t h i o t h r e i t o l . The 
mixture was incubated a t 37°C for 4 hr, a f t e r which 0.1 ml of 
iodoacetic acid (72.0 mg in 0.5N NaOH) was added and pH was 
maintained a t 8.0 with 0.5N NaOH. The react ion mixture was 
s t i r r e d in dark for 30 minutes* 
(11) Hydrolysis with ohymotrypsin and gel f i l t e r a t i o n 
The incubated material was digested with chymotr3rp3in for 
4 hr a t 37°C and subjected to gel f i l t r a t i o n through Sephadex G-25 
column previously equi l ibrated.with 0.5M sodium bicarbonate 
containing 0.02 percent sodium az ide . 
i,0 
( i l l ) Pur i f icat ion of peptides of 0-subunit 
Further pur i f ica t ion of peptides of 0-hCQ was done on 
Sephadex Gr-50 column. Each aubunit in PBS containing 8M urea 
and 5 mW EDTA was loaded onto a column of Sephadex G-50 
(1.8cm X 55cm) previously equi l ibra ted with PBS. f ract ions (2.5 ml) 
were col lected a t a flow r a t e of 20 ml/hr. 
26. I so la t ion and Puri f icat ion of Anti-Peptide Antibodies from 
Anti*-hCG Immune Sera 
Anti-peptide antibodies were i so la ted from anti-hCG immune 
sera by a f f in i ty chromatography. 
( i ) Preparation of peptlde-Sepharose 4B column 
Sepharose 4B gel was washed with d i s t i l l e d water on 
s in tered glass funnel. 5 gm of moist gel was mixed with 20 ml 
of 2M NagCO^ a t 4®C, One gm of CNBr was dissolved in 0.6 ml 
of ace ton i t r i l e and kept a t 4°C. CNBr solut ion was added 
dropwise to the mixture and contents were mixed for 15-20 minutes 
in cold. The mixture was f i l t e r e d through s in te red g lass funnel 
kept a t -20*^C and washed with 0.1M NagCO^ containing 0.5M NaCl 
(coupling buffer ) . The gel was then t ransferred to a stoppered 
cyl inder containing 8-10 mg of pept ide . The contents wei»e mixed 
(end-over-end) a t room temperature for 2 hr and then kept a t 
4°C for 14 h r s . 
The coupled gel was mixed again for 1 hr a t room temperature 
and tfffireafter f i l t e r e d on the s intered g lass funnel and washed 
tl 
with approximately 200 ml of 0.1M NaHCO,. After washing with 
1M ethanolamine the slurry was transferred to stoppered cylinder 
containing approximately 50 ml of 1M ethanolamine to block 
unoccupied sites. The gel was mixed (end-over-end) for 2 hrs 
at room temperature, filtered and washed with 200 ml of 0.1M 
NaHCO, and then with 200 ml of 0.1M acetate buffer, pH 4,0 and 
finally with PBS for equilibration, 
(ii) Purification of antl-peptide antibodies by affinity 
chromatography 
A solution of 10 mg/ml of crude gammaglobulins of anti-
hCG was dialyzed in PBS and applied onto affinity column 
(3cm x 6cffl), The column was washed with PBS to remove unbound 
material. The bound material was eluted with 6M urea in PBS, The 
elaate was immediately dialyzed against PBS to remove urea and 
concentrated. 
t u 
R E S U L T S 
1. Purification of Biman Chorionic Gonadotropin (hCG) 
Commercially available hCO waa purified by gel f i l te ra t ion 
chromatography on Sephadsx 0-100 in 0.05M phosphate buffer, 
pH 7*5 (Fig.5)« l^ he hormone sample was contaminated with subunits 
and unbound sugar contents. The f i r s t major peak was intact hCG 
whereas other peaks were due to microbeterogeneity of the hormone 
molecule. The fractions of f i r s t ma;}or peak were pooled* 
concentrated and again loaded onto same f i l te ra t ion medium. The 
f i r s t major keap (Fig.6) was pooled and used in subsequent 
studies. 
2 . Polyaorylamide Gel Blootrophoresis (PAGE) 
Commercially available and purified hormone samples were 
subjected to polyaorylamide gel electrophoresis. The impure hCG 
showed heterogeneity (Fig.7A) v^ereas the purified hormone was 
found to be homogeneous with respect to charge and exhibited a 
single electrophoretic band (Fig.7B). 
The aubunit composition of purified hCG was determined bySDS 
PAGE (Fig.8). The sample was found constituting two subunits 
designated as alpha subunit (a, low molecular weight) and beta 
subunit (3, high molecular weight). The omission of 
3-mereaptoethanol had no effect on electrophoretic mobility of 
subunits, suggesting that these subunits are held together by 
non-covalent bonds. 
20 30 
FRACTION NUMBER 
Fig,5. Gel filtration of commercial hCG on Sephadex G 100 
column. 
Column size : 1.8 x 66.0cm; eluent : 0.05M 
phosphate buffer, pH 7.5; fraction size : 2.5 ml; 
flow rate: 18 ml/hr. Fraction under peak I were 
pooled, dialyzed against 0.05M phosphate buffer 
pH 7.5 and again loaded to the same column. 
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Fig, 6. Elution profile of purified hCG on Sephadex G 100 
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Fig.7. Polyacrylamide gel electrophoretic pattern of 
commercial and purified hCG. . 
A = commercial hCG; B = purified hCG. 
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Fig,8, Sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) of hCG. = 
I 100 Mg Of hCG was electrophoresed in 10 percent 
polyacrylamide gel containing 0.1 percent SDS. The 
gel was stained with Coomassie Blue, a and 3 
represents the alpha and beta-subunits of hCG. 
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3. Effect of m Radiation on hCG 
(i) Fluoresoenoe differenoe spectra 
The fluorescence spectral properties of hCQ were studied 
at pH 7.5. The native hormone exhibited a single emission maximum 
at 350 nm when excited with 280 nm (Fig.9). On irradiation with 
different UV doses of wavelength 254 nm, the hormone showed a 
dose dependent loss in intrinsic fluorescence intensity. The 
fluorescence difference spectra were constructed by substracting 
fluorescence intensity values of irradiated hCG from those of 
native hCO at various emission wavelengths (Fig,10). The 
difference spectra exhibited two emission maxima at 350 nm and 
410 nm. The first one is the characteristic maxima of protein 
but the second maxima might be due to the scattering of light, 
(ii) Ultraviolet spectra 
UV absorption spectra of native and irradiated hCG were 
recorded in the spectral range from 230 nm to 400 nm. Both 
native and irradiated hCG showed a maximum at 275 nm and minimum 
at 250 nm (Fig,1l). The irradiated hCG exhibited decreased 
absorption over entire spectral range and the decrease at 275 nm 
was proportional to radiation dose (Table 3 ) . 
4. Modification of Lysine Residues of hCG 
2,4,6 trinitrobenzene sulfonic acid (TNBS) which is 
generally considered to be an amino group specific reagent 
(Ogiso et al, 1974| Ernest and Kim, 1974) was used to modify 
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Fig ,9. Ultraviolet and fluorescence spectra of native hCG. 
Hormone (500 Mg/ml) was dissolved in phosphate 
buffer, pH 7.5. Ultraviolet ( • ) and 
fluorescence spectra ( o ), 
< 
B, 
350 AOO A50 
WAVELENGTH , nm 
Fig.10. Fluorescence difference spectra of photoinactivated 
hCG. 
The hormone (500 Mg/ml) was in 0.05M phosphate 
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buffer, pH 7 .5 . Radiation doses 18.2 x 10 ergs cm 
( 7 -2 ); 36,4 X 10 ergs cm ( O ) and 
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Hormone (500 Mg/ml) was in phosphate 
buffer^ pH 7 . 5 . Native ( ) and 
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TABI£ III 
Ultraviolet absorption at 275 nm of native and irradiated hCG 
Radiation dose 
-7 -.2 
X 10' ergs cm 
Absorbance at 275 nm 
Absorbanoe 
0.508 
0.312 
0.283 
0.274 
Ptercent decrease 
-
36.58 
44.29 
46.06 
Native 
18.2 
36.4 
54.6 
free lysine amino groups of hCG. The kinetics of the lysine 
residue modification was monitored. Total number of lysine 
residues of hCQ have been imported to be 10 (Morgan et al, 1975). 
In the present studies, the trlnitrophenylatlon of only 6 lysine 
residues (Fig,12) in native hCG suggests that the remaining four 
lysine residues are burrled in the molecule and thus inaccessible 
7 —2 to the reagent. The irradiated (18.2 x 10 ergs cm ) hCO showed 
5 trinitrophenylated lysine residues. On two fold increase in 
the radiation dose, almost no effect was observed in the number 
of lysine residue modified. 
5, Tryptio Digestibility of hCG 
The susceptibility of native and irradiated bCQ to 
tryptlc digestion was checked in terms of number of moles of 
additional amino groups exposed after proteolytic digestion. 
The results (Fig.13) showed that native hCG which is a compact 
structure (Ingham et al, 1976) is completely resistant to tryptlc 
attack even after its Incubation with trypsin for 2 hrs. However, 
7 -2 
after Irradiation at a dose of 18.2 x 10 ergs cm hCG became 
susceptible to tryptlc attack. With increased radiation dosesn 
the susceptibility to trypsin was found decreased. 
6. Effect of Radiation on Reducing Sugars 
Reducing sugars v^re estimated in native and Irradiated 
hCG samples (Fig.14). Their contents were found increased with 
radiation dose. 
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Fig.12. Kinetics of modification of lysine residues of native 
and i r rad ia ted hCG with 2 ,4 ,6- t r ini t robenzene sulfonic 
acid (TNBS). 
Native hCG ( o • ) ; 18.2 x W ergs cm~^, 
i r rad ia ted hCG ( • ) and 36.4 x 10 ergs cm 
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Fig,13. Effect of ultraviolet Irradiation on tryptic digesti-
bility of hCG. 
Native hCG ( • ); 18.2 x 10 ergs cm""^  
7 "~2 ( — f — • ) 36.4 X 10 ergs cm (--o ) and 
54.6 X lo'^  ergs cm~^ ( o^  ) irradiated hCG. 
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Fig.lA, Effect of i r r ad ia t ion on reducing sugars . 
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7. Unfolding of hCO by Urea 
The fluorescence Intensity of hCO at 350 nm is due to 
the presence of aromatic amino acids. Perturbation of the 
environment of these amino acid by treatment of the hormone with 
a denaturant is expected to alter its intrinsic fluorescence. 
Therefore, urea denaturation of hCO was followed by monitoring 
the loss in its intrinsic fluorescence at 350 nm during unfolding 
process. 
The concentration range of urea over which the native 
hCG was denatured is tsrpical for globular proteins (Tanford, 
1968). The hormone resists unfolding only upto 1 M urea (Fig,15), 
but as the urea concentration is increased, it is abruptly 
denatured suggesting that subunits of hCG are held together with 
non~covalent bonds and denaturation is a two state process i.e. 
native -^ denatured. Relatively higher concentration of urea 
was needed for complete unfolding of the molecule. A significant 
change in the unfolding behaviour of irradiated hCG was noticed. 
8. Antibody Activity Measurements in Immune Sera 
Antibodies were raised in rabbits both against native 
7 —2 
and irradiated hCG (18.2 x 10 ergs cm ) with Freund's complete 
adjuvant. The level of induced antibodies was checked by 
counterimmunoelectrophoresis (CIE) and ELISA on polystyrene 
plates. Precipitating antibodies were obtained with hCG as 
antigen (Fig.16). The antibody recognized irradiated hCG but to 
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Fig,16. Antibodies against hCG detected by CIE. 
A = anti-hCG immune sera, B = native hCG, 
7 -2 
J C = 18.2 X 10 ergs, cm irradiated hCG, 
7 -2 D = 36.4 X 10 ergs cm irradiated hCG and 
7 —2 E = 54,6 X 10 ergs cm irradiated hCG. 
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a lower extent. At higher irradiation doses, the hCQ fail to 
form precipition lines. Direct binding ELI3A of antisera against 
irradiated hCG (Fig.17) showed increased antibody level with 
increased period of immunization. The absorbance of less than 
0.1 was taken as cut off value for the computation of serum 
titer. The titer of antisera was found to be 1:0, 1j100, 1:400 
and 1:1600 after first, second, third and fourth infections 
respectively. The results also indicate that a minimum of two 
injections are required for detectable antibody activity. 
9. Immunohistology of Rat Testes 
In case of control rats, testis showed normal seminiferous 
tubules and spermatogenesis. However, when hCG was in^cted into 
the rat, the testis showed seminiferous tubules with increased 
spermatogenesis. The tubules were filled fully with mature 
^erms. While in case of irradiated hCO injected rat, testis 
showed normal seminiferous tubules with inhibited maturation, 
suggesting that normal sperm formation did not take place. Pew 
Sertoli cells were also damaged and a decrease in their number 
was evident (shown by arrow. Fig.18). 
10. Dark Binding of Psoralen to hCO 
Information on the binding between psoralen and h(XJ was 
—6 first obtained by equilibrium dialysis. With 1.35 x 10 M 
hormone in 0.05 M phosphate buffer, pH 7.4 containing 0.9% NaCl 
~5 
and 5.38 x 10 M psoralen at room temperature, over 32 percent 
2.0 3.0 1.0 
• -LOG SERUM TITER 
Fig,17. Direct binding of hCG by induced antibodies against 
i r r ad ia ted hCG. 
7 -2 
I r rad ia t ion dose: 18.2 x 10 ergs cm . Preimmunized 
( — o ); immunized rabbit sera after second injection 
( • ); after third injection ( O ) and after 
fourth injection ( • ). Inset: serum titer with 
respect to immunization sheduled. 
Fig. 18. Piistology of r a t t e s tes a f t e r immunization, 
A = Buffer (PBS); B = Native hCG and 
C = I r rad ia ted hCG. 
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of the drug was found in the bound state. The results were 
indicative of affinity of psoralen for the protein hormone and 
prompted us to a quantitative evaluation of the parameters of 
binding. For this purpose, we used spectroscopic methods which 
are rapid and require low amounts of materials for the measurements, 
The method was based on the quenching of intrinsic fluorescence 
of psoralen on binding to hCO. 
(i) Ultraviolet spectra 
UV absorption spectra of native and bound psoralen with 
hCO were taken in the spectral range of 200 nm to 370 nm. Both 
unbound and hCQ-bound psoralen showed maximum absorption at 245 nm 
and 295 nm and minimum at 225 and 265 nm (Fig,19A). The hCO-
psoralen complex exhibited increased absorbance over entire 
spectral range. When the complex (hCQ-psoralen) was dialyzed 
extensively against phosphate buffer (0.05 M phosphate buffer, 
pH 7.4 containing 0.9% NaCl) the spectra showed maxima at 275 nm 
and a dip at 250 nm. An increased absorption as a result of 
complex formation was noticed but without a change in its 
pattern (Fig.19B). 
(ii) Fluorescence ap«ctra 
Fluorescence spectra was recorded in a spectral range of 
370 nm to 530 nm by exciting the samples at 330 nm, the excita-
tion maxima of psoralen (Fig,20). There was no change in the 
emission wavelength of hCO-psoralen complex but a decrease in 
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F i g . 2 0 . Fluorescence spec t ra of hCGf-psoralen complex in dark . 
Psoralen ( • • ) and hCG-psoralen complex 
( O — ) . 
fluorescence intensity was noticed as compared to the fluorescence 
intensity of unbound psoralen. 
(iii) Kinetic treatment of dark interaction 
Scatchard plot for the interaction between psoralen and 
hCO was derived from the fluorescence quenching titration at a 
fixed concentration of hormone (Fig,21). The fluorescence 
intensity of psoralen at its emission maxima decreases upon 
their interaction with hCG and reaches a minimum, when the hCG 
gets saturated with psoralen. By asstuning that the amount of 
fluorescence quenching is directly proportional to the amount of 
psoralen bound to hCXJ, the values of C- and C, were calculated, 
where C^ and C, are the concentrations of free and bound psoralen 
respectively. The apparent association constant, K for 
interaction of hCG with psoralen was calculated by Scatchard 
analysis (Scatchard, 1949) which predicts that 
L- « K (n-r) 
where, n is the apparent number of independent binding 
sites of hCO for psoi^len, r is the ratio of concentration of 
bound psoralen to the total concentration of hCG used. The 
apparent association constant, K , for the drug was calculated 
from the slope of the Scatchard plot (Fig.21) at low r values. 
The plot indicated the involvement of four binding sites 
4—1 (r » 3.9) with an association constant, KQ of 0.795x10 M . 
So 
LO 
' O 
o 
Fig.21, Scatchard plot for binding of psoralen to hCG in 
dark. 
The concentration of hCG was kept constant 
(1.35 X 10 M) while that of psoralen was varied 
-5 -5 
from 1.07 x 10 to 5.38 x 10 M. Fluorescence 
emission intensity was measured at the excitation 
maxima of psoralen. 
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In Fig.22 the binding parameter r vs Cf has been computed, 
With increase in free psoralen concentration, the number of 
binding sites have also increased. Uhder these experimental 
conditions, the percent quenching of psoralen fluorescence is 
decreased (Fig.23). 
(Iv) Gel filteration 
In addition to fluorescence quenching, the binding 
capaf.ity of psoralen to hCG was also checked by gel filteration 
experiments. There was no change in elution volume of hCQ and 
hCG-psoralen complex but a significant increase in 280 nm 
absorption of the complex was noted (Fig.24). 
11. Inhibition by Psoralen in Immunoreactivity of hCO-Anti 
hCG Interaction 
Psoralen caused a concentration dependent inhibition of 
hCO-anti-hCO-antibody interaction as depicted in Fig.25* With 
a increase in the concentration of psoralen, there is gradual 
decrease in immunoreactivity. A parallelism betv^en two 
parameters was obtained at a saturation point (i.e. 60 ng of 
psoralen) followed by a plateau which is persistant till 100 ng 
of psoralen, 
12. Detection of Antibodies in Immune Sera 
Antibodies raised in rabbits against hCG and hCO psoralen 
complex with Freund's complete adjuvant were checked for 
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r e a c t i v i t y by ELISA on polystyrene p l a t e s . ( F i g . 2 6 ) . After t h i r d 
Inject loni the leve l of antibodies was progressively Increased. 
The t i t e r s of an t l sera were 1i1920, 1:15360 and 1s491520 a f t e r 
t h i r d , fourth and f i f t h Injections respec t ive ly . No appreciable 
antibody a c t i v i t y was found with preImmunized rabbi t serum. The 
complex was found to be more ant igenic than unbound hCG (Fig .27) . 
IgO isola ted from hCO psoralen an t l se ra was checked for 
binding c h a r a c t e r i s t i c s . Fig.28 shows the r e s u l t s obtained with 
d i f ferent concentration of IgG in ELISA using hCQ and hCG-psoralen 
complex as ant igens . The complex was found to be more react ive 
than unbound hCO for antl-hCXl-psoralen IgQ. 
13 . Specif ic i ty of Anti-hCQ Antibodies 
The spec i f i c i ty of anti-hCG antibodies was checked by 
inh ib i t i on experiments. Varying concentrations of inh ib i to r s 
(hCO, 0hCO and ahCG) were mixed with 1t5000 d i lu ted serum and 
incubated a t 37*^ C for 2 hrs and a t 4°C for 18 h r s . 
Maximum Inhibi t ion was obtained by hCJG followed by alpha 
and beta subunlts (Fig,29) . The respective values were 60%, 55% 
and 33?^. 
14. Specif ic i ty of Anti-hCXI-Paoralen Antibodies 
(1) With antlsera 
Fig.30 shows the results obtained by inhibition ELISA. 
High degree of specificity was evident since 68^ inhibition was 
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Fig.29. Inhibition ELISA with anti-hCG antibodies. 
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Fig.30. Inhibi t ion ELISA with anti-hCG-psoralen ant ibodies . 
Inhibi tors were hCG ( O ) , hCG-psoralen 
complex ( • ) , alpha-subunit ( • ) and 
beta-subunit ( o ) . 
I.. . 
achieved with hCO-psoralen followed by 5696 with hCO,4296 with 
alpha subunit and 26.3196 with beta subunit of hCG a t an inh ib i to r 
concentration of 20 Mg/ml, 
( i i ) With i so la ted IgO 
Varying concentrations of inh ib i to rs (hCG-psoralen, hCG, 
alpha subunit and beta subunit, 0.1 Mg - 2.5 Mg) were mixed with 
5 Mg of anticomplex IgG. The extent of inh ib i t ion obtained with 
hCO-psoralen, hCO, alpha subunit and beta subunit was 5496, 4896, 
3096 and 20.396 respect ively a t an inh ib i to r concentration of 1,0 
Mg ( P i g . 3 l ) . 
15. Effect of UV-A Light upon Binding of Psoralen to hCO 
(1) Ul t raviole t measurements 
HCXJ, psoralen and hCO-psoralen complex were i r r ad ia t ed 
8 —2 —"1 
with UV-A (365 nm) l i g h t a t a dose rate 10.2 x 10 ergs cm min. 
UV spectra a f t e r i r r ad ia t ion was taken in a spec t ra l range of 
230 nm to 400 nm before and a f t e r extensive d i a ly s i s against 
phosphate buffer (Fig.32) . Both hCG and hCG-psoralen complex 
a f t e r i r r ad i a t i on showed s imilar pa t tern of spectra but the 
complex exhibited increased absorbance over e n t i r e spec t ra l range. 
The difference spectra (Fig,32C) i s indicat ive of psoralen 
in te rac t ion with hCG on exposure to UV-A l i g h t . 
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Fig.31, Inhibition ELISA with anti-hCG-psoralen IgG. 
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hCG ( ---O ), alpha-subunit ( • ) and beta-
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(11) Fluorescence laeaaurements 
-6 
A fixed concentration of hCO (1.35 x 10 M) and psoralen 
(1.07 X 10 M) were UV-A Iri^dlated for different time periods 
(Fig.33). As the radiation time was increased, fluorescence 
intensity of the complex and psoralen was increased and there 
was a linear relationship between the difference in fluorescence 
intensity of psoralen and hCGKpsoralen complex (Fig.33 inset). 
(ill) Effect of drug concentration upon binding 
A fixed concentration of hCG (1.35 x 10*" M) and a varying 
concentration of psoralen (1.07 x 10""^ M to 5.38 x 10~^M) were 
mixed and irradiated as described in Experimental. It was found 
that with increase in drug concentration the fluorescence intensity 
was also increased (Fig.34). 
16. Fluorescence Transition of hCG in 8M Urea 
Kinetics of unfolding of hCQ was followed by monitoring 
loss in fluorescence intensity with respect to denaturation time. 
The fluorescence transition curve for hCG was constructed by 
plotting fractions denatured, fo vs time (Fig.35). The hormone 
was mixed with urea in a final concentration of 200 Mg/ml in 8 M 
urea and fluorescence intensity was monitored at 350 tm. The 
kinetic analysis of the denaturation process was performed by 
the method of Warren et al (1974) using first order rate equations 
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Fig .33 . Effect of i r r ad ia t ion time on binding, capacity of 
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( • ) . Inset : Difference in fluorescence 
i n t e n s i t i e s of hCG-psoralen complex and psoralen 
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Fig.35, Effect of urea on stability of hCG. 
Values of f^ were calculated using equation 
given in experimental. hCG concentration 
1.35 X 10 M in 0.05M phosphate, pH 7.4 containing 
0.9% of NaCl; Urea: 8M. 
10 
where Y^ and Yt are the percent change in fluorescence 
intensity of hCG a t the end of denaturation process (1 hr, Y^o ) 
and at part icular time respectively (y^). The -log (Xxj- Yt) 
values were plotted against denaturation time and slope of the 
l ine , m, was related to the apparent f i r s t order rate constant 
for denaturation process. Plot of fluorescence transmission 
(Fig,35) showed the process to occur in a single phase, 
17. Dark Binding of Psoralen to Subunlts of hCG 
In order to study the binding of psoralen to alpha and 
beta subunlts of hCG, the fluorometric properties of free and 
bound (with subunlts) psoralen were compared. The alpha-psoralen 
and beta-psoralen complexes exhibited no change in relative 
excitation and emission wavelenths but a significant quenching 
was observed (Fig.36 and 37). 
(1) Ultraviolet spectra 
The IN spectra of psoralen and i t s complex with alpha 
and beta subunlts was recorded (Fig.38). A sl ight shift in 
wavelength of the alpha-psoi^len complex was noted. Psoralen 
exhibited two characteristic maxima one a t 245 nm and other at 
295 nm. The alpha-psoralen complex showed a single emission peak 
a t 290 nm (Fig,38). Similarly beta-psoralen complex have a maxima 
a t 285 nm, different from psoralen maxima of 295 nm (Fig.39). 
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Fig.36. Fluorescence spectra of dark in te rac t ion between alpha-
subunit and psoralen, 
A = exc i ta t ion spectra; B = emission spec t ra . 
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Fig.37. Fluorescence spectra of dark in te rac t ion between beta-
subunit and psoralen. 
A = exci ta t ion spectra; B = emission spect ra . 
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(ii) Gel filteratlon 
In addit ion to spectroscopic studies the binding of 
psoralen to subunits was checked by gel f l l t e r a t l o n experiments. 
There was no change in e lu t lon behaviour of alpha subunit and 
alpha-psoralen complex but a increased absorbance was noticed 
(Fig.40A). Similar r e su l t s were obtained with beta subunit and 
beta-psoralen complex (Fig.AOB). 
18. Antigenicity of Subunits 
Antibodies against alpha~3Ubunit, alpha-psoralen, beta-
subunit and beta-psoralen complex were ra ised in rabb i t with 
Freund's complete adjuvant and t h e i r t i t e r was determined by 
ELISA. The d i rec t binding of ant i -a lpha subunit and an t i - a lpha -
psoralen complex antibodies with hCO-showed a t i t e r of 1:51200 
and 113200 respect ively (Flg ,41) . Similarly, the t i t e r of a n t i -
beta subunit and ant i -beta-psoralen complex antibodies was 
1:51200 and I1I6OO respect ively (Fig .42) . Normal rabb i t sera 
did not show any appreciable binding. 
The an t igen ic i ty of subunits and t h e i r complexes were 
evaluated a f t e r each Immunization. Subunits of hCG appears to 
be more antigenic than t h e i r respective complexes (Fig. 43 and 44) . 
19. Chymotrypsin Digestion of Beta-Subunlt 
As a r e s u l t of digestion by a-chymotrypain of 0-rsubunit, 
th ree peptides were obtained by gel f i l t e r a t i o n on Sephadex Ci-25. 
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These peptides have been designated as PI, PII and P H I 
(Fig .45) . The individual pooled f ract ions were concentrated 
and passed through a column of Sephadex G-50 (Fig .46) . The peak 
f rac t ions were pooled and concentrated and used in subsequent 
s t ud i e s . 
20. Binding of Antl-hCO Antibodies with Peptides 
The binding of anti-hCG antibodies with peptides was 
studied by competition experiments (Fig .47) . At a concentration 
of 100 Mg/ml of peptides, in hCG-antl-hCG-antibody a c t i v i t y , 
inh ib i t ion was observed to the extent of 66% for PI, kk%t for PH 
and no inhib i t ion for P H I , 
2 1 . Binding of Antl-Beta-Subunit Antibodies with Peptides 
The r e s u l t s of inhib i t ion ELISA are shown in Fig.48. 
At a concentration of 100 Mg/ml, the inhib i t ion was 52?6 for 
peptide I , 36% for peptide I I and no inh ib i t ion for peptide I I I . 
22. Affinity Iso la t ion of Anti-Peptide IgO 
Anti-PI antibodies were i so la ted from anti-hCG sera by 
a f f i n i t y chromatography using a column of Sepharose 4B coupled 
with peptide I . 
Affinity purif ied an t i -P I antibodies were checked for 
r e a c t i v i t y with hCG, beta subunit and alpha subunit immobilized 
on polystyrene p l a t e s . The r e su l t s showed maximum a c t i v i t y with 
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Fig.45. Gel f i l t e r a t i o n a f te r hydrolysis of carboxymethylated 
beta-subunit by chymotrypsin on Sephadex G-25 column. 
Column s i ze : 1.5 x 50cm; eluent ; 0.5M NaHCO ;^ 
fract ion s i ze ; 2.0 ml; flow r a t e : 15 ml/hr. Fraction under 
the peak I , I I and I I I were pooled separate ly , concentrated 
and dialysed against the same eluent and fur ther applied 
to a G-50 column. 
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Fig,48. Inhibi tory capacity of peptides of beta-subunit against 
anti-beta-hCG ant ibodies . 
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Ui 
hCG followed by beta-subunit. With alpha subunit only a slight 
binding was observed (Fig.49). 
When peptide I, peptide II and peptide III were coated 
on polystyrene plates, affinity purified IgQ showed binding with 
peptide I, whereas peptide II and peptide III showed comparatively 
weak binding activity (Fig,50). 
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Fig.49. Reactivity of a f f in i ty pur i f ied anti-peptideI-IgG 
(ant i -PI ) with different ant igens . 
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Fig.50. Reactivity of affinity purified anti-peptide I-IgG 
(anti-PI) with different peptide of beta-subunit. 
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and peptide I I I ( o . ) , 
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D I S C U S S I O N 
The concept of vaccine against pregnancy ia an a t t r a c t i v e 
approach to f e r t i l i t y control and the one which has received 
increasing a t t en t ion in the l a s t decade. The p i t u t a ry 
l u t e in i z ing hormone (LH) and chorionic gonadotropin (hCG) 
excercise a c r i t i c a l role in regulat ion of f e r t i l i t y of pr imates. 
In view of the high degree of homology between hCG and IM, i t 
has been quite d i f f i c u l t to generate hCG specif ic ant ibodies 
t h a t were generated against hCG. 3o the hCG and i t s subunits 
were modified in various ways (Stevens and Crystlep 1973j 
Pandian e t a l , 1980j Iwasa e t a l , 1981j Covey and Laurence, 1984 
Caraux e t a l , 1985j Gupta e t a l , 1985) to minimize the cross 
r e a c t i v i t y against LH. 
A number of physico-chemical s tudies have been performed 
in order to obtain information concerning the overall,conforma-
t i on of hCG, but h i the r to , the determination of the three 
dimensional s t ructure of e i t he r the i n t a c t horaone or i t s free 
subunits has remained unsolved. Immunochemical methods have 
recent ly been u t i l i z e d to define antigenic s i t e s on the three 
dimensional surface of hCG and i t s subunits (Ehrlich e t a l , 19851 
Schwarz e t a l , 1986). The major deterrent in the case of hCG 
has been the d i f f i cu l ty in i t s pu r i f i ca t ion . Even highly 
pur i f ied preparations display microheterogeneity. However, the 
source of microheterogeneity has been recognized and i s due to 
I'c 
the variation in their carbohydrate content and not in the 
polypeptide chain. The fluctuation in the carbohydrate units 
is probably due to their degradation or incomplete synthesis. 
It is consistent with the accepted view that tlie monosaccharides 
are attached stepwise to the completed poljrpeptide chain in the 
smooth endoplasmic reticulum by appropriate glycosyl transferase 
and sugar nucleosides (3piro, 1970). It is therefore conceivable 
that the carbohydrate units would be at various stages of 
completion at the time of isolation of a glycoprotein. 
The fluorescence intensity of proteins has been reported 
to be sensitive towards the structural purturbations induced 
in the molecule (Konev» 1967). Protein fluorescence is primarily 
due to the emission from tyrosine and tryptophan fluorophores. 
In spite of the presence of both the fluorophores, hCG exhibited 
a single emission peak of tyrosine at 350 nm and lacks the peak 
of tryptophan, The results are consistent with the obseivation 
that tryptophan residues are absent in hCG molecule 
(Morgan et al, 1975). 
Absorbance at 275 nm of irradiated hCO decreased with 
increasing radiation dose. This may be ascribed either to the 
photodestruction of tryrosine residues or the exposure of these 
residues to hydrophillic environment upon unfolding of the hCG 
molecule. The decrease in absorbance of hCQ is consistent with 
the destruction of these residues by quantitative analysis, 
Photodestruction of these residues resulted in the change in 
hormone conformation. 
1 clij 
The changes in structure of the hormone induced by-
radiation have been detected by monitoring the susceptibility 
of stinicturally altered protein to proteol3rtic enzymes. In the 
present study, the resistance of native hCG towards tryptic 
attack is consistent with the fact that most of the protein in 
their native state remain unhydrolyzed by proteolytic enzyme 
due to non-availability of sites. However, after UV radiation, 
hCO became progressively susceptible to tryptic digestion. This 
marked difference in the behaviour of native and photoinactivated 
hCG indicates that these two forms of hormone have two different 
conformation. In the former case, the sites for typtic attack 
are hurried, while, in the later these were accessible to 
trjrpsin due to change in structure of the molecule. However, as 
the radiation dose increased, the susceptibility of hCO to 
trypsin decreased. This might be due to either the destruction 
of amino acids that are susceptible to digestion or there is a 
partial change in confoimation of irradiated hCG molecule in 
such way that amino acids are no more accessible to trypsin 
digestion. The hormone contains 11 ai^inine and 7 lysine 
residues (Bahl, 1969) which contribute the possible sites for 
tryptic attack. 
The influence of protein denaturant, urea, on the stability 
of hCG, showed that noncovalent bonds are barely sufficient to 
stabilize the native structure of hCG. The data on urea 
inactivation of native and irradiated hCG showed differences in 
their structural stability. Native hCG is more susceptible to 
u, 
urea denaturation as compai^d to irradiated hCO as the photo-
inactivated hCG needs high concentration of urea for complete 
unfolding. The difference might be due to the change in 
stnjcture on account of irradiation. 
The antibodies against irradiated hCG cross-react with 
hCG but appreciably less binding was noticed. During photo-
inactivation, the native structure of hCG is probably disrupted, 
resulting in partial loss of immunogenicity. This was confirmed 
by immunohistological studies. Native hCG was biologically active 
and enhanced the process of spenaatogenesis so as to the full 
maturation of sperms. However, photoinactivated hCG arrested 
spermatogenesis and the sperms did not reach maturation stage. 
These results confirm that immunogenicity and biological activity 
are associated with the native structure of hCG and UV irradia-
tion has affected the native structure of the molecule with 
decreased biological activity. 
The evaluation of the percentage of psoralen bound 
in vitro to hCG was evaluated by operating the experiment under 
physiological conditions with regard to pH and ionic strength 
(Veronese et al, 1978). A direct evaluation of the binding ot 
psoralen to hCG by usual methods, such as ultrafilteration by 
Araincon centriflow membrane or under pressure by Diaflo 
membrane were not feasible because 8-MOP has been reported to 
bind atroTigly to these membrane filters (Veronese et al, 1978). 
c a 
flellable data were obtained by equilibriuia dialysis and 
fluorescence quenching techniques. The study of quenching of 
extrinsic as well as intrinsic bound fluorophores has proved to 
have great significance in studying the ligand-protein interaction 
(Eftink and Ghiron, 1981). This analysis is shown in terms of 
Scatchard plot based on the fact that intrinsic fluorescence 
of psoralen was quenched significantly after interaction with 
hCG. 
A slight curvature in the binding data indicated two 
possible modes of binding (a) increase in psoralen concentration 
restricts its further interaction with hCG (b) low affinity 
sites are also involved in the binding reaction. 
The data obtained by fluorescence quenching indicated 
5 -1 four binding sites for psoralen on hCG with Ka » 0.795 x 10"^  M . 
Preliminary data of equilibrium dialysis yielded a value of 
Ka » 0.33 X 10 M showing a definite correlation between these 
two altogether different techniques. Effective competition was 
observed between anti-hCG antibodies and psoralen for the binding 
sites on hCG molecule. The results clearly indica'te that there 
was inhibition in the immunoreactivity of hCG-anti-hCG system 
by the psoralen. This revealed that the psoralen binding sites 
and epitope might be identical or recognizing the sai^ amino 
acid(s) on the hCG molecule. 
Immunological studies on hCG-psoralen complex has suggested 
that binding of psoralen to hCO results in enhanced immunogenlclty. 
J2 
Anti-hCG-psoralen antibodies bind hCG with high a f f i n i t y as 
compared to antl-hCG ant ibodies . Therefore, the neut ra l iz ing 
capacity of antl-hCG-psoralen an t i se ra would be grea te r as 
compared to unbound hCQ. The react ion was found t o be specif ic 
as is shown by inh ib i t ion experiments. 
The immunological s tudies on the subunlt and t h e i r 
complexes with psoralen showed t h a t subunits a f t e r binding with 
psoralen became l e s s immunogenic and Induced decreased amount 
of antibodies as compared to ant l -subuni t an t ibodies . The 
decreased an t igen ic i ty might be due to e i t he r nonavai lab i l i ty 
of epitopes due to psoralen binding in the near v i c i n i t y of the 
ant igenic s i t e s or the binding of psoralen to a key amino acid 
of antigenic s i t e rendering i t l e s s immunogenic* 
Amino acid sequences of the ^-subunits of hCG and LH 
had marked difference between them. The 0-3ubunit of hCQ contains 
not only the unique carboxy-terminal 30 residue peptide but a lso 
some other sequences in the r e s t of the molecule. The immunologic 
proper t ies of the synthet ic carboxy-end of 3-hCO but smaller 
than the natural fragment have been reported. These sequences 
have prepared both by chemical synthesis (Schneider e t a l , 1975J 
Matsuura e t a l , 1978j Caraux e t a l , 1985) and by enzymatic 
cleavage (Louvet e t a l , 1974). In the present study, we have 
used the chymotryptic digested three peptides of 0-subunit . The 
antibodies against peptide I (PI) from anti-hCG serum were 
i so la ted on the column of 3epharose-4B covalently l inked to PI . 
loU 
The isolated antibodies against PI showed binding with hCG as 
well as with 3hC0 but exhibited low level of reactivity with 
ahCQ. It appears that tte antigenic determinants of PI are a 
part of hCG and 0hCG but not of ahCG. Moreover, the antibodies 
did not show binding towards polypeptides PII and PHI of lower 
molecular weight. The antibodies are thus specific for PI. 
The recognition of antibodies induced against hCG and 
3hCG with a series of enzymatically digested peptide clearly 
indicates that the antibody recognition sites of hCG/0hCG reside 
within PI and PII. The results show among these two peptides 
the major reactivity is present in peptide PI with low reactivity 
in PH. \iftiile the antigenic determinants on the surface of the 
hCG molecule have not been thoroughly defined in structural terms, 
it is clear that despite the great similarity of amino acid 
sequences of 3-subunit, there is at least one conformationally 
determined epitope that is relatively specific for hCG 
(Vaitukaitis et al, 1972| Birken et al, 1980| Pandian et al, 1980). 
In conclusion, this study clearly indicates that photo-
inactivation caused altered native structure of hCG molecule 
which results in decreased immunological and biological properties. 
Furthermore the binding of psoralen to hCG and its subunits was 
confirmed and evaluated by fluorescence quenching experiments. 
Although, it is difficult to locate the exact binding position 
of psoralen of hCG but epitope and binding site appears to be 
similar. The studies on peptides of ^ -subunit showed that major 
reactivity of hCG and 3-hCG was present in PI with somewhat low 
reactivity in PII. 
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